MARK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Log-Odds: S Sites / S Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00267 | S804 | Sugiyama | SUPT5H SPT5 SPT5H | tPMYGsQtPLQDGsRtPHyGsQtPLHDGsRtPAQsGAWDPN |
| O00410 | S726 | Sugiyama | IPO5 KPNB3 RANBP5 | LMVPLLKFYFHDGVRVAAAEsMPLLLECARVRGPEYLTQMW |
| O00468 | S641 | Sugiyama | AGRN AGRIN | PRCEHPPPGPVCGSDGVTyGsACELREAACLQQtQIEEARA |
| O00541 | S282 | Sugiyama | PES1 | EGTyALDSESCMEKLAALsAsLARVVVPATEEEAEVDEFPt |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15013 | S1282 | Sugiyama | ARHGEF10 KIAA0294 | PDAAIWLGDSLGSMTQKsDLssssGsLsLsHGsssLEHRSE |
| O15226 | S618 | Sugiyama | NKRF ITBA4 NRF | VNKIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQ |
| O15355 | S349 | Sugiyama | PPM1G PPM1C | tTAVVALIRGKQLIVANAGDsRCVVsEAGKALDMsyDHKPE |
| O15460 | S531 | Sugiyama | P4HA2 UNQ290/PRO330 | KWVSNKWFHERGQEFLRPCGstEVD________________ |
| O43290 | S378 | Sugiyama | SART1 | DGLRERELEEIRAKLRLQAQsLSTVGPRLASEYLtPEEMVT |
| O43290 | S624 | Sugiyama | SART1 | IGWSTVNLDEEKQQQDFSASsTtILDEEPIVNRGLAAALLL |
| O43318 | S439 | Sugiyama | MAP3K7 TAK1 | GNILDVPEIVISGNGQPRRRsIQDLtVtGTEPGQVssRsss |
| O43399 | S96 | Sugiyama | TPD52L2 | ELKRRLGLstLGELKQNLsRsWHDVQVssAyVKTSEKLGEW |
| O43707 | S763 | Sugiyama | ACTN4 | IARTINEVENQILtRDAKGIsQEQMQEFRASFNHFDKDHGG |
| O43815 | S227 | Sugiyama | STRN | NGTEAEVKETAMIAKSELtDsAsVLDNFKFLEsAAADFsDE |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O60291 | S515 | Sugiyama | MGRN1 KIAA0544 RNF156 | sFItEEVDESssPQQGTRAAsIENVLQDssPEHCGRGPPAD |
| O60333 | S1057 | Sugiyama | KIF1B KIAA0591 KIAA1448 | DNEYFNQSDFSSVAMTRsGLsLEELRIVEGQGQSSEVItPP |
| O60664 | S179 | Sugiyama | PLIN3 M6PRBP1 TIP47 | QSGVDKTKsVVtGGVQsVMGsRLGQMVLsGVDtVLGKsEEW |
| O60749 | S119 | Sugiyama | SNX2 TRG9 | AVtPVtPttLIAPRIESKsMsAPVIFDRsREEIEEEANGDI |
| O60763 | S32 | Sugiyama | USO1 VDP | SAGPQHTEAEtIQKLCDRVAssTLLDDRRNAVRALKSLSKK |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75390 | S453 | Sugiyama | CS | LAQLIWSRALGFPLERPKSMsTEGLMKFVDSKSG_______ |
| O75822 | S127 | Sugiyama | EIF3J EIF3S1 PRO0391 | VLtPEEQLADKLRLKKLQEEsDLELAKEtFGVNNAVyGIDA |
| O94776 | S54 | Sugiyama | MTA2 MTA1L1 PID | ANGNVEAKVVCLFRRRDIsssLNSLADSNAREFEEESKQPG |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95376 | S113 | Sugiyama | ARIH2 ARI2 TRIAD1 HT005 | LILVNFHWQVSEILDRYKSNsAQLLVEARVQPNPSKHVPTS |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| O95819 | S800 | Sugiyama | MAP4K4 HGK KIAA0687 NIK | DVEQEGADESTSGPEDTRAAsSLNLSNGETESVKTMIVHDD |
| P00338 | S105 | Sugiyama | LDHA PIG19 | VTANsKLVIItAGARQQEGEsRLNLVQRNVNIFKFIIPNVV |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P02545 | S295 | Sugiyama | LMNA LMN1 | RQsAERNsNLVGAAHEELQQsRIRIDsLsAQLsQLQKQLAA |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S78 | Sugiyama | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05023 | S520 | Sugiyama | ATP1A1 | EPQHLLVMKGAPERILDRCssILLHGKEQPLDEELKDAFQN |
| P05198 | S219 | Sugiyama | EIF2S1 EIF2A | CYGYEGIDAVKEALRAGLNCsTENMPIKINLIAPPRYVMTT |
| P06280 | S176 | Sugiyama | GLA | AQTFADWGVDLLKFDGCYCDsLENLADGYKHMSLALNRTGR |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P07195 | S106 | Sugiyama | LDHB | VtANSKIVVVtAGVRQQEGEsRLNLVQRNVNVFKFIIPQIV |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07195 | S44 | Sugiyama | LDHB | ITVVGVGQVGMACAISILGKsLADELALVDVLEDKLKGEMM |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07339 | S42 | Sugiyama | CTSD CPSD | VRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQAVPAV |
| P07384 | S474 | Sugiyama | CAPN1 CANPL1 PIG30 | GQPAVHLKRDFFLANAsRARsEQFINLREVSTRFRLPPGEY |
| P07437 | S40 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | FWEVISDEHGIDPTGtyHGDsDLQLDRIsVyyNEAtGGKyV |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | S747 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | ETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVREL |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S164 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGT |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P08238 | S159 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGT |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P09923 | S189 | Sugiyama | ALPI | RVQHAsPAGtyAHtVNRNWysDADMPASARQEGCQDIATQL |
| P0CAP2 | S187 | Sugiyama | POLR2M GRINL1A | EASEHHPRHRVssQAEDtSssFDNLFIDRLQRITIADQGEQ |
| P10398 | S157 | Sugiyama | ARAF ARAF1 PKS PKS2 | SSKVPTVCVDMSTNRQQFyHsVQDLsGGsRQHEAPsNRPLN |
| P10636 | S235 | iPTMNet|EPSD | MAPT MAPTL MTBT1 TAU | KEEVDEDRDVDESsPQDsPPsKAsPAQDGRPPQTAAREATS |
| P10636 | S579 | GPS6|SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | RLQTAPVPMPDLKNVKsKIGstENLKHQPGGGKVQIINKKL |
| P10636 | S610 | GPS6|EPSD | MAPT MAPTL MTBT1 TAU | GKVQIINKKLDLsNVQsKCGsKDNIKHVPGGGsVQIVyKPV |
| P10636 | S622 | GPS6|EPSD | MAPT MAPTL MTBT1 TAU | sNVQsKCGsKDNIKHVPGGGsVQIVyKPVDLSKVTsKCGsL |
| P10636 | S637 | SIGNOR | MAPT MAPTL MTBT1 TAU | VPGGGsVQIVyKPVDLSKVTsKCGsLGNIHHKPGGGQVEVK |
| P10636 | S641 | GPS6|SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | GsVQIVyKPVDLSKVTsKCGsLGNIHHKPGGGQVEVKSEKL |
| P10636 | S673 | GPS6|SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | QVEVKSEKLDFKDRVQsKIGsLDNITHVPGGGNKKIEtHKL |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P11137 | S1540 | SIGNOR|EPSD | MAP2 | FKQAKDKVSDGVtKsPEKRssLPRPSSILPPRRGVsGDRDE |
| P11137 | S1679 | SIGNOR|EPSD | MAP2 | QLRLINQPLPDLKNVKsKIGsTDNIKYQPKGGQVQIVTKKI |
| P11137 | S1710 | SIGNOR|EPSD | MAP2 | GQVQIVTKKIDLSHVTSKCGsLKNIRHRPGGGRVKIESVKL |
| P11137 | S1795 | SIGNOR|EPSD | MAP2 | GAEIItQsPGRssVAsPRRLsNVsssGsINLLEsPQLATLA |
| P11137 | S1799 | SIGNOR|EPSD | MAP2 | ItQsPGRssVAsPRRLsNVsssGsINLLEsPQLATLAEDVT |
| P11137 | S1802 | SIGNOR|EPSD | MAP2 | sPGRssVAsPRRLsNVsssGsINLLEsPQLATLAEDVTAAL |
| P11137 | S385 | iPTMNet | MAP2 | SFKIEEPHEAKPDKMAEAPPsEAMTLPKDAHIPVVEEHVMG |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11279 | S141 | Sugiyama | LAMP1 | NLSDTHLFPNASSKEIKtVEsITDIRADIDKKYRCVSGTQV |
| P11586 | S765 | Sugiyama | MTHFD1 MTHFC MTHFD | ARMFGIPVVVAVNAFKTDTEsELDLIsRLSREHGAFDAVKC |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12814 | S744 | Sugiyama | ACTN1 | IARTINEVENQILtRDAKGIsQEQMNEFRAsFNHFDRDHsG |
| P13473 | S155 | Sugiyama | LAMP2 | LTVDELLAIRIPLNDLFRCNsLSTLEKNDVVQHYWDVLVQA |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13489 | S225 | Sugiyama | RNH1 PRI RNH | KLEsCGVTSDNCRDLCGIVAsKASLRELALGSNKLGDVGMA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13667 | S470 | Sugiyama | PDIA4 ERP70 ERP72 | FAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAMEP |
| P13797 | S540 | Sugiyama | PLS3 | NDDIIVNWVNRTLSEAGKSTsIQSFKDKTISSSLAVVDLID |
| P13798 | S187 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | EKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQFV |
| P13798 | S27 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | LsEPEEAAALyRGLSRQPALsAACLGPEVtTQyGGQyRTVH |
| P14314 | S108 | Sugiyama | PRKCSH G19P1 | PSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQ |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S447 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | PKyLNFVKGVVDsDDLPLNVsREtLQQHKLLKVIRKKLVRK |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P16949 | S46 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | PRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAEERRKsHEA |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P18206 | S809 | Sugiyama | VCL | ELsKtIsPMVMDAKAVAGNIsDPGLQKsFLDsGyRILGAVA |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S356 | Sugiyama | NCL | LAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKVFGNEI |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P20618 | Y158 | Sugiyama | PSMB1 PSC5 | IGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLD |
| P20674 | S104 | Sugiyama | COX5A | PEPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYP |
| P21108 | S11 | Sugiyama | PRPS1L1 PRPS3 PRPSL | __________MPNIKIFsGssHQDLSQKIADRLGLELGKVV |
| P21333 | S2152 | Sugiyama | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P21333 | S2158 | Sugiyama | FLNA FLN FLN1 | GRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQDMtAQV |
| P22059 | S386 | Sugiyama | OSBP OSBP1 | ITMPENLGHKRtGsNIsGAssDIsLDEQyKHQLEETKKEKR |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P23284 | S150 | Sugiyama | PPIB CYPB | LKHyGPGWVsMANAGKDTNGsQFFITTVKTAWLDGKHVVFG |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P24534 | S174 | Sugiyama | EEF1B2 EEF1B EF1B | DMAKLEECVRsIQADGLVWGssKLVPVGyGIKKLQIQCVVE |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25054 | S1861 | Sugiyama | APC DP2.5 | DsPHHytPIEGTPYCFsRNDsLssLDFDDDDVDLSREKAEL |
| P26232 | S667 | Sugiyama | CTNNA2 CAPR | YDVRsRtsVQtEDDQLIAGQsARAIMAQLPQEEKAKIAEQV |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P27448 | S96 | Sugiyama | MARK3 CTAK1 EMK2 | ILTGREVAIKIIDKtQLNPtsLQKLFREVRIMKILNHPNIV |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27816 | S1073 | SIGNOR|ELM|iPTMNet|EPSD | MAP4 | DVKIEsQKLNFKEKAQAKVGsLDNVGHLPAGGAVKTEGGGS |
| P27816 | S928 | SIGNOR|iPTMNet|EPSD | MAP4 | PTSAKPssttPRLSRLAtNtsAPDLKNVRsKVGstENIKHQ |
| P27816 | S941 | SIGNOR|ELM|iPTMNet|EPSD | MAP4 | SRLAtNtsAPDLKNVRsKVGstENIKHQPGGGRAKVEKKTE |
| P28066 | S180 | Sugiyama | PSMA5 | GtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLI |
| P28838 | S180 | Sugiyama | LAP3 LAPEP PEPS | YEYDDLKQKKKMAVSAKLyGsGDQEAWQKGVLFAsGQNLAR |
| P28838 | S194 | Sugiyama | LAP3 LAPEP PEPS | SAKLyGsGDQEAWQKGVLFAsGQNLARQLMETPANEMTPtR |
| P29144 | S176 | Sugiyama | TPP2 | FDVANNGSsQANKLIKEELQsQVELLNsFEKKYSDPGPVYD |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30086 | S54 | Sugiyama | PEBP1 PBP PEBP | VDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAP |
| P30622 | S195 | Sugiyama | CLIP1 CYLN1 RSN | AAKEPsAtPPISNLTKtAsEsIsNLsEAGsIKKGERELKIG |
| P31327 | S537 | Sugiyama | CPS1 | GVELFKRGVLKEYGVKVLGtsVEsIMATEDRQLFSDKLNEI |
| P31327 | S835 | Sugiyama | CPS1 | MCHPsIEGFTPRLPMNKEWPsNLDLRKELSEPSsTRIyAIA |
| P34897 | S90 | Sugiyama | SHMT2 | GLELIAsENFCsRAALEALGsCLNNKYSEGYPGKRyyGGAE |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | T364 | Sugiyama | HSPA4 APG2 HSPH2 | ATRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAILs |
| P35221 | S668 | Sugiyama | CTNNA1 | FDVRsRtsVQtEDDQLIAGQsARAIMAQLPQEQKAKIAEQV |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P35606 | S350 | Sugiyama | COPB2 | MGDAEIKDGERLPLAVKDMGsCEIyPQtIQHNPNGRFVVVC |
| P35613 | S228 | Sugiyama | BSG UNQ6505/PRO21383 | EPMGTANIQLHGPPRVKAVKssEHINEGEtAMLVCKSEsVP |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39748 | S255 | Sugiyama | FEN1 RAD2 | CESIRGIGPKRAVDLIQKHKsIEEIVRRLDPNKYPVPENWL |
| P40818 | S718 | Sugiyama | USP8 KIAA0055 UBPY | AKPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtP |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P46013 | S1098 | Sugiyama | MKI67 | PAARVTGMKKWPRtPKEEAQsLEDLAGFKELFQtPGPsEEs |
| P46013 | S651 | Sugiyama | MKI67 | ISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLGAKQ |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46940 | S1448 | Sugiyama | IQGAP1 KIAA0051 | AIRDAKTPDKMKKsKsVKEDsNLtLQEKKEKIQTGLKKLTE |
| P46940 | S482 | Sugiyama | IQGAP1 KIAA0051 | LINRALESGDVNTVWKQLsssVtGLTNIEEENCQRYLDELM |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49321 | S662 | Sugiyama | NASP | LKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsstsGF |
| P49327 | S265 | Sugiyama | FASN FAS | TILNAGTNTDGFKEQGVtFPsGDIQEQLIRSLyQsAGVAPE |
| P49368 | S458 | Sugiyama | CCT3 CCTG TRIC5 | RAVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtW |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P49736 | S170 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | KRRQVERAtEDGEEDEEMIEsIENLEDLKGHSVREWVsMAG |
| P49790 | S607 | Sugiyama | NUP153 | KtPPEDCEGPFRPAEILKEGsVLDILKsPGFAsPKIDSVAA |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50395 | S427 | Sugiyama | GDI2 RABGDIB | ttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED__ |
| P50402 | S29 | Sugiyama | EMD EDMD STA | DtELttLLRRyNIPHGPVVGstRRLyEKKIFEyEtQRRRLs |
| P51946 | S15 | Sugiyama | CCNH | ______MYHNsSQKRHWtFSsEEQLARLRADANRKFRCKAV |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52597 | S187 | Sugiyama | HNRNPF HNRPF | KALGKHKERIGHRYIEVFKssQEEVRsysDPPLKFMsVQRP |
| P52597 | S63 | Sugiyama | HNRNPF HNRPF | VHFIYTREGRQsGEAFVELGsEDDVKMALKKDRESMGHRyI |
| P53621 | S389 | Sugiyama | COPA | SYNPAENAVLLCTRAsNLENstyDLytIPKDADsQNPDAPE |
| P53999 | S56 | Sugiyama | SUB1 PC4 RPO2TC1 | PVKKQKTGETsRALsssKQssssRDDNMFQIGKMRYVSVRD |
| P53999 | S58 | Sugiyama | SUB1 PC4 RPO2TC1 | KKQKTGETsRALsssKQssssRDDNMFQIGKMRYVSVRDFK |
| P54105 | S42 | Sugiyama | CLNS1A CLCI ICLN | DTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSLEYPTIS |
| P54252 | S260 | Sugiyama | ATXN3 ATX3 MJD MJD1 SCA3 | IDMEDEEADLRRAIQLsMQGssRNIsQDMtQtsGTNLTSEE |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55769 | S122 | Sugiyama | SNU13 NHP2L1 | CSVTIKEGSQLKQQIQsIQQsIERLLV______________ |
| P55957 | S78 | Sugiyama | BID | QtDGNRssHsRLGRIEADsEsQEDIIRNIARHLAQVGDsMD |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60891 | S11 | Sugiyama | PRPS1 | __________MPNIKIFsGssHQDLSQKIADRLGLELGKVV |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61163 | T248 | Sugiyama | ACTR1A CTRN1 | PQKDETLETEKAQyyLPDGstIEIGPSRFRAPELLFRPDLI |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61326 | S106 | Sugiyama | MAGOH MAGOHA | QELEIVIGDEHISFTTSKIGsLIDVNQSKDPEGLRVFYYLV |
| P61916 | S29 | Sugiyama | NPC2 HE1 | LLLALSTAAQAEPVQFKDCGsVDGVIKEVNVsPCPtQPCQL |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62241 | S115 | Sugiyama | RPS8 OK/SW-cl.83 | TLVKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEE |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S57 | Sugiyama | YWHAZ | sNEERNLLsVAyKNVVGARRssWRVVssIEQKTEGAEKKQQ |
| P63104 | S58 | Sugiyama | YWHAZ | NEERNLLsVAyKNVVGARRssWRVVssIEQKTEGAEKKQQM |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63220 | S65 | Sugiyama | RPS21 | RFNGQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF__ |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P78371 | S470 | Sugiyama | CCT2 99D8.1 CCTB | IADNAGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAI |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| Q00587 | S350 | Sugiyama | CDC42EP1 BORG5 CEP1 MSE55 | HyPEMDARQERVEVLPQARAsWEsLDEEWRAPQAGsRtPVP |
| Q00613 | S375 | Sugiyama | HSF1 HSTF1 | TDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLDAMDSNL |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01581 | S404 | Sugiyama | HMGCS1 HMGCS | YSLKVTQDATPGSALDKITAsLCDLKSRLDSRTGVAPDVFA |
| Q01650 | S35 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | AAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNITLLNG |
| Q02878 | S255 | Sugiyama | RPL6 TXREB1 | tEKEKYEITEQRKIDQKAVDsQILPKIKAIPQLQGYLRSVF |
| Q04637 | S1238 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | RDAVKREAALPPVsPLKAALsEEELEKKsKAIIEEyLHLND |
| Q04721 | S1621 | Sugiyama | NOTCH2 | KKQRMTRRSLPGEQEQEVAGsKVFLEIDNRQCVQDSDHCFK |
| Q04726 | S622 | Sugiyama | TLE3 KIAA1547 | VWDLHNQTLVRQFQGHTDGAsCIDISHDGTKLWTGGLDNTV |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q07021 | S213 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | VGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDSLDW |
| Q08209 | S492 | Sugiyama | PPP3CA CALNA CNA | EAKGLDRINERMPPRRDAMPsDANLNsINKALTSETNGTDS |
| Q08379 | S123 | Sugiyama | GOLGA2 | SQNHDADNVPNLMDETKTFSsTESLRQLSQQLNGLVCESAT |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q09666 | S220 | Sugiyama | AHNAK PM227 | QsGKtVIRLPsGsGAAsPtGsAVDIRAGAIsAsGPELQGAG |
| Q12931 | S361 | Sugiyama | TRAP1 HSP75 HSPC5 | SIFYVPDMKPSMFDVSRELGsSVALYSRKVLIQTKATDILP |
| Q13098 | S483 | Sugiyama | GPS1 COPS1 CSN1 | QIHVKsPPREGsQGELtPANsQsRMstNM____________ |
| Q13098 | S485 | Sugiyama | GPS1 COPS1 CSN1 | HVKsPPREGsQGELtPANsQsRMstNM______________ |
| Q13136 | S338 | Sugiyama | PPFIA1 LIP1 | MEERITTLEKRYLAAQREATsVHDLNDKLENEIANKDSMHR |
| Q13136 | S668 | Sugiyama | PPFIA1 LIP1 | EEKENTEQRAEEIESRVGsGsLDNLGRFRSMssIPPYPAss |
| Q13164 | T553 | Sugiyama | MAPK7 BMK1 ERK5 PRKM7 | KRRQERERKERGAGASGGPStDPLAGLVLsDNDRsLLERWT |
| Q13200 | S147 | Sugiyama | PSMD2 TRAP2 | SVLAMTMSGERECLKYRLVGsQEELASWGHEYVRHLAGEVA |
| Q13263 | S473 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13283 | S362 | Sugiyama | G3BP1 G3BP | LFIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGF |
| Q13283 | S67 | Sugiyama | G3BP1 G3BP | sNGKPADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLN |
| Q13347 | S217 | Sugiyama | EIF3I EIF3S2 TRIP1 | sRDMtMFVtASKDNTAKLFDsttLEHQKTFRTERPVNSAAL |
| Q13470 | S502 | SIGNOR|PSP | TNK1 | PPARGQRRNMPLERMKGIsRsLEsVLsLGPRPtGGGssPPE |
| Q13765 | S186 | Sugiyama | NACA HSD48 | sEEEEVDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDI |
| Q14141 | T418 | Sugiyama | SEPTIN6 KIAA0128 SEP2 SEPT6 | QRKTAAELLQsQGsQAGGsQtLKRDKEKKNNPWLCTE____ |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14192 | S238 | Sugiyama | FHL2 DRAL SLIM3 | AKKCAGCTNPISGLGGtKyIsFEERQWHNDCFNCKKCsLsL |
| Q14204 | S3257 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | NDKLKKMVKDQQEAEKKKVMsQEIQEQLHKQQEVIADKQMS |
| Q14258 | S340 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | KPVYIPEVELNHKLIKGIHQstIDLKNELKQCIGRLQEPTP |
| Q14568 | S164 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGT |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14677 | S163 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | DRLREERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSK |
| Q14738 | S598 | Sugiyama | PPP2R5D | DVyTIKALEAHKRAEEFLTAsQEAL________________ |
| Q14789 | S1568 | Sugiyama | GOLGB1 | RDKLITEMDRSLLENQSLSssCEsLKLALEGLTEDKEKLVK |
| Q14974 | S531 | Sugiyama | KPNB1 NTF97 | LETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQKTT |
| Q14980 | S1181 | Sugiyama | NUMA1 NMP22 NUMA | DsALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQD |
| Q15075 | S356 | Sugiyama | EEA1 ZFYVE2 | QATLHQKDLDCQQLQsRLsAsEtsLHRIHVELSEKGEATQK |
| Q15293 | S80 | Sugiyama | RCN1 RCN | HEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGDGFVt |
| Q155Q3 | S592 | EPSD|PSP | DIXDC1 CCD1 KIAA1735 | QVGSEYRESWPPNSKLPHsQssPTVSSTCTKVLYFTDRSLT |
| Q15642 | S296 | Sugiyama | TRIP10 CIP4 STOT STP | FARPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRS |
| Q15785 | S8 | Sugiyama | TOMM34 URCC3 | _____________MAPKFPDsVEELRAAGNESFRNGQyAEA |
| Q15818 | S91 | Sugiyama | NPTX1 | TILSQKETIRELTAKLGRCEsQsTLDPGAGEARAGGGRKQP |
| Q16204 | S325 | Sugiyama | CCDC6 D10S170 TST1 | QRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQGL |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16531 | T1125 | Sugiyama | DDB1 XAP1 | MQEVVANLQYDDGSGMKREAtADDLIKVVEELtRIH_____ |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16658 | S237 | Sugiyama | FSCN1 FAN1 HSN SNL | RsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALE |
| Q53EL6 | S46 | Sugiyama | PDCD4 H731 | GDEENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKN |
| Q5BKZ1 | Y93 | Sugiyama | ZNF326 ZIRD | PYESyDsRsSLGGRDLYRsGyGFNEPEQSRFGGSYGGRFES |
| Q5T035 | S66 | Sugiyama | FAM120A2P C9orf129 | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPI |
| Q5VT06 | S2431 | Sugiyama | CEP350 CAP350 KIAA0480 GM133 | SCRDKPQPMRSSTSGATSFGsNEEISECLSEKsLSIHSNVH |
| Q5VT52 | S1070 | Sugiyama | RPRD2 KIAA0460 HSPC099 | TATDQQQQEEHYRIETRVsssCLDLPDSTEEKGAPIETLGy |
| Q5VWQ8 | S747 | Sugiyama | DAB2IP AF9Q34 AIP1 KIAA1743 | ssysEANEPDLQMANGGKsLsMVDLQDARTLDGEAGsPAGP |
| Q6FI81 | S170 | Sugiyama | CIAPIN1 CUA001 PRO0915 | ESDNLLFVQITGKKPNFEVGsSRQLKLsITKKssPsVKPAV |
| Q6GYQ0 | T798 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | tGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDMS |
| Q6NVY1 | S381 | Sugiyama | HIBCH | PADLKEVtEEDLNNHFKSLGsSDLKF_______________ |
| Q6P1J9 | S178 | Sugiyama | CDC73 C1orf28 HRPT2 | EGHKEGIVQTEQIRSLsEAMsVEKIAAIKAKIMAKKRSTIK |
| Q6P996 | S722 | Sugiyama | PDXDC1 KIAA0251 | PGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPEQI |
| Q6PID6 | S19 | Sugiyama | TTC33 | __MASFGWKRKIGEKVSKVTsQQFEAEAADEKDVVDNDEGN |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q7L2H7 | S367 | Sugiyama | EIF3M HFLB5 PCID1 GA17 PNAS-125 | WQQLyDTLNAWKQNLNKVKNsLLsLsDt_____________ |
| Q7Z2W4 | S492 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | VQATGRIADDADPRVALVNDsLsDVtsTtssRVDDHDSEEI |
| Q7Z417 | S671 | Sugiyama | NUFIP2 KIAA1321 PIG1 | DsWGsFDLRAAIVYHTKEMEsIWNLQKQDPKRIItyNEAMD |
| Q7Z460 | S1196 | Sugiyama | CLASP1 KIAA0622 MAST1 | EEIYSSLRGVTEAIEKFsFRsQEDLNEPIKRDGKKECDIVs |
| Q7Z460 | S545 | Sugiyama | CLASP1 KIAA0622 MAST1 | yHTLESSyQKALQSHLKNSDsIVsLPQsDRsssssQEsLNR |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q86VQ1 | S226 | Sugiyama | GLCCI1 | sCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQRSKQ |
| Q86W92 | S636 | Sugiyama | PPFIBP1 KIAA1230 | RGGTRATAGPRLGWsRDLGQsNsDLDMPFAKWTKEQVCNWL |
| Q8IUD2 | S824 | Sugiyama | ERC1 ELKS KIAA1081 RAB6IP2 | KKKsAQMLEEARRREDNLNDsSQQLQDSLRKKDDRIEELEE |
| Q8IZP0 | S22 | Sugiyama | ABI1 SSH3BP1 | AELQMLLEEEIPSGKRALIEsyQNLTRVADyCENNyIQATD |
| Q8N806 | S265 | Sugiyama | UBR7 C14orf130 | KDDVREVKVEQNsEPCAGsssEsDLQtVFKNESLNAESKSG |
| Q8TDD1 | S624 | Sugiyama | DDX54 | FQQGQQGRQEQQEGPVGPAPsRPALQEKQPEKEEEEEAGEs |
| Q8WU90 | S351 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLsEAs |
| Q8WUI4 | S155 | ELM | HDAC7 HDAC7A | PPVPSLPSDPPEHFPLRKtVsEPNLKLRYKPKKSLERRKNP |
| Q8WWI1 | S1421 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | yDIPKTEEAsSGFLPGDRNKsRsttELDDYSTNKNGNNKYL |
| Q8WWI1 | S1510 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RsAsVNKEPVSLPGIMRRGEsLDNLDsPRSNSWRQPPWLNQ |
| Q8WWI1 | S704 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | KKRLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEM |
| Q8WWI1 | S706 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEMQK |
| Q8WXH0 | S2781 | Sugiyama | SYNE2 KIAA1011 NUA | ILSQIRKCKVTHDGILARQQsVEsLAEEVKDKVPSLTTYEG |
| Q92609 | S541 | Sugiyama | TBC1D5 KIAA0210 | EsMPVQLNKGLSSKNIsssPsVEsLPGGREFtGsPPssAtK |
| Q92626 | S1300 | Sugiyama | PXDN KIAA0230 MG50 PRG2 PXD01 VPO VPO1 | NITRVQSDVFRVAEFPHGyGsCDEIPRVDLRVWQDCCEDCR |
| Q92973 | S339 | Sugiyama | TNPO1 KPNB2 MIP1 TRN | SDIDIILLKGDVEEDEtIPDsEQDIRPRFHRSRTVAQQHDE |
| Q92974 | S711 | Sugiyama | ARHGEF2 KIAA0651 LFP40 | sGGNtsPGVtANGEARTFNGsIELCRADsDssQRDRNGNQL |
| Q93045 | S80 | Sugiyama | STMN2 SCG10 SCGN10 | PPsPISEAPRTLAsPKKKDLsLEEIQKKLEAAEERRKsQEA |
| Q96A72 | S108 | Sugiyama | MAGOHB MAGOH2 | QELEIVIGDEHISFTTSKIGsLIDVNQSKDPEGLRVFYYLV |
| Q96D15 | S98 | Sugiyama | RCN3 UNQ239/PRO272 | ARLGRIVDRMDRAGDGDGWVsLAELRAWIAHTQQRHIRDsV |
| Q96JP5 | S177 | Sugiyama | ZFP91 ZNF757 FKSG11 | TSVSRHRDTENTRSSRSKTGsLQLICKSEPNTDQLDYDVGE |
| Q96KP4 | S58 | Sugiyama | CNDP2 CN2 CPGL HEL-S-13 PEPA | RGEIRRMMEVAAADVKQLGGsVELVDIGKQKLPDGSEIPLP |
| Q96N67 | S1438 | Sugiyama | DOCK7 KIAA1771 | LGTYTIAsPPERsPsGsAFGsQENLRWRKDMTHWRQNTEKL |
| Q96S59 | S181 | Sugiyama | RANBP9 RANBPM | QEtPLPRSWsPKDKFsYIGLsQNNLRVHYKGHGKTPKDAAS |
| Q96S59 | S613 | Sugiyama | RANBP9 RANBPM | DCDtEMEVDSsQLRRQLCGGsQAAIERMIHFGRELQAMSEQ |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99689 | S58 | EPSD|PSP | FEZ1 | LEDPSLSELENFSSEIISFKsMEDLVNEFDEKLNVCFRNYN |
| Q9BX40 | S165 | Sugiyama | LSM14B C20orf40 FAM61B RAP55B | GFPSIPVGKsPMVEQAVQtGsADNLNAKKLLPGKGTTGTQL |
| Q9BX40 | T163 | Sugiyama | LSM14B C20orf40 FAM61B RAP55B | GAGFPSIPVGKsPMVEQAVQtGsADNLNAKKLLPGKGTTGT |
| Q9C0C2 | S1158 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | sPssKMEGGHFVPPGKttAGsVDWTDQLGLRNLEVssCVGs |
| Q9H0H5 | S257 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | ETVPYWtRSRRKtGtLQPWNsDstLNSRQLEPRTETDsVGt |
| Q9H2G2 | S518 | Sugiyama | SLK KIAA0204 STK2 | tVDLVSQEtGEKEANIQAVDsEVGLTKEDtQEKLGEDDKTQ |
| Q9H501 | Y72 | Sugiyama | ESF1 ABTAP C20orf6 HDCMC28P | AVDKRGRPISHSTTEDLKRFyDLsDsDsNLsGEDSKALSQK |
| Q9H7E9 | T40 | Sugiyama | C8orf33 | PCAsRGARLPGPVsSARNPstVCLCPEQPTCSNADSRAHPL |
| Q9HA77 | S548 | Sugiyama | CARS2 OK/SW-cl.10 | TLRRGLTAHGINIKDRssttstWELLDQRTKDQKSAG____ |
| Q9HCN4 | S301 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | ANAESQQQREQLERLRKDMGsVALDAGtAKDsLsPVLHPsD |
| Q9HCN8 | S40 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | ALLVPGGGAAKTGAELVTCGsVLKLLNTHHRVRLHSHDIKY |
| Q9HD42 | S101 | Sugiyama | CHMP1A CHMP1 KIAA0047 PCOLN3 PRSM1 | TMKGVTKNMAQVTKALDKALsTMDLQKVSSVMDRFEQQVQN |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NR19 | S30 | Sugiyama | ACSS2 ACAS2 | sGsGSRGQEEAGAGGRARsWsPPPEVsRSAHVPSLQRYREL |
| Q9NYB9 | S22 | Sugiyama | ABI2 ARGBPIA | AELQMLLEEEIPGGRRALFDsytNLERVADyCENNyIQSAD |
| Q9NZ52 | S415 | Sugiyama | GGA3 KIAA0154 | LCLGLADPAPNVPPKESAGNsQWHLLQREQsDLDFFSPRPG |
| Q9NZB2 | S417 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPI |
| Q9P0L2 | S100 | Sugiyama | MARK1 KIAA1477 MARK | VLTGREVAVKIIDKTQLNPTsLQKLFREVRIMKILNHPNIV |
| Q9P0L2 | S20 | Sugiyama | MARK1 KIAA1477 MARK | _MSARTPLPTVNERDTENHTsVDGytEPHIQPTKSSSRQNI |
| Q9P0L2 | S382 | Sugiyama | MARK1 KIAA1477 MARK | MATYILLGRKPPEFEGGESLssGNLCQRsRPssDLNNstLQ |
| Q9P0L2 | S383 | Sugiyama | MARK1 KIAA1477 MARK | ATYILLGRKPPEFEGGESLssGNLCQRsRPssDLNNstLQs |
| Q9P0L2 | S393 | Sugiyama | MARK1 KIAA1477 MARK | PEFEGGESLssGNLCQRsRPssDLNNstLQsPAHLKVQRSI |
| Q9P0L2 | S399 | Sugiyama | MARK1 KIAA1477 MARK | ESLssGNLCQRsRPssDLNNstLQsPAHLKVQRSISANQKQ |
| Q9P0L2 | S403 | Sugiyama | MARK1 KIAA1477 MARK | sGNLCQRsRPssDLNNstLQsPAHLKVQRSISANQKQRRFs |
| Q9P0L2 | S423 | Sugiyama | MARK1 KIAA1477 MARK | sPAHLKVQRSISANQKQRRFsDHAGPSIPPAVsYTKRPQAN |
| Q9P0L2 | S435 | Sugiyama | MARK1 KIAA1477 MARK | ANQKQRRFsDHAGPSIPPAVsYTKRPQANsVEsEQKEEWDK |
| Q9P0L2 | S444 | Sugiyama | MARK1 KIAA1477 MARK | DHAGPSIPPAVsYTKRPQANsVEsEQKEEWDKDVARKLGst |
| Q9P0L2 | S447 | Sugiyama | MARK1 KIAA1477 MARK | GPSIPPAVsYTKRPQANsVEsEQKEEWDKDVARKLGsttVG |
| Q9P0L2 | S46 | Sugiyama | MARK1 KIAA1477 MARK | EPHIQPTKSSSRQNIPRCRNsITsAtDEQPHIGNYRLQKTI |
| Q9P0L2 | S463 | Sugiyama | MARK1 KIAA1477 MARK | NsVEsEQKEEWDKDVARKLGsttVGsKsEMTAsPLVGPERK |
| Q9P0L2 | S470 | Sugiyama | MARK1 KIAA1477 MARK | KEEWDKDVARKLGsttVGsKsEMTAsPLVGPERKKsstIPS |
| Q9P0L2 | S475 | Sugiyama | MARK1 KIAA1477 MARK | KDVARKLGsttVGsKsEMTAsPLVGPERKKsstIPSNNVYS |
| Q9P0L2 | S485 | Sugiyama | MARK1 KIAA1477 MARK | tVGsKsEMTAsPLVGPERKKsstIPSNNVYSGGsMARRNtY |
| Q9P0L2 | S486 | Sugiyama | MARK1 KIAA1477 MARK | VGsKsEMTAsPLVGPERKKsstIPSNNVYSGGsMARRNtYV |
| Q9P0L2 | S49 | Sugiyama | MARK1 KIAA1477 MARK | IQPTKSSSRQNIPRCRNsITsAtDEQPHIGNYRLQKTIGKG |
| Q9P0L2 | S498 | Sugiyama | MARK1 KIAA1477 MARK | VGPERKKsstIPSNNVYSGGsMARRNtYVCERTTDRYVALQ |
| Q9P0L2 | S588 | Sugiyama | MARK1 KIAA1477 MARK | TIKDGSEAYRPGTTQRVPAAsPsAHsISTAtPDRTRFPRGS |
| Q9P0L2 | S590 | Sugiyama | MARK1 KIAA1477 MARK | KDGSEAYRPGTTQRVPAAsPsAHsISTAtPDRTRFPRGSSS |
| Q9P0L2 | S593 | Sugiyama | MARK1 KIAA1477 MARK | SEAYRPGTTQRVPAAsPsAHsISTAtPDRTRFPRGSSSRst |
| Q9P0L2 | S624 | Sugiyama | MARK1 KIAA1477 MARK | FPRGSSSRstFHGEQLRERRsVAyNGPPAsPSHETGAFAHA |
| Q9P0L2 | S633 | Sugiyama | MARK1 KIAA1477 MARK | tFHGEQLRERRsVAyNGPPAsPSHETGAFAHARRGTsTGII |
| Q9P0L2 | S711 | Sugiyama | MARK1 KIAA1477 MARK | EGKDSKPRSLRFTWSMKTTSsMDPNDMMREIRKVLDANNCD |
| Q9P0L2 | T25 | Sugiyama | MARK1 KIAA1477 MARK | TPLPTVNERDTENHTsVDGytEPHIQPTKSSSRQNIPRCRN |
| Q9P0L2 | T464 | Sugiyama | MARK1 KIAA1477 MARK | sVEsEQKEEWDKDVARKLGsttVGsKsEMTAsPLVGPERKK |
| Q9P0L2 | T465 | Sugiyama | MARK1 KIAA1477 MARK | VEsEQKEEWDKDVARKLGsttVGsKsEMTAsPLVGPERKKs |
| Q9P0L2 | T487 | Sugiyama | MARK1 KIAA1477 MARK | GsKsEMTAsPLVGPERKKsstIPSNNVYSGGsMARRNtYVC |
| Q9P0L2 | T51 | Sugiyama | MARK1 KIAA1477 MARK | PTKSSSRQNIPRCRNsITsAtDEQPHIGNYRLQKTIGKGNF |
| Q9P0L2 | Y24 | Sugiyama | MARK1 KIAA1477 MARK | RTPLPTVNERDTENHTsVDGytEPHIQPTKSSSRQNIPRCR |
| Q9P1Y5 | S431 | Sugiyama | CAMSAP3 KIAA1543 | FGLDSDVDVVMGDPVLLRsVssDsLGPPRPAPARTPtQPPP |
| Q9P265 | S203 | Sugiyama | DIP2B KIAA1463 | stsssASSTLSHGEVKGtsGsLADVFANtRIENFSAPPDVT |
| Q9P2E9 | S1233 | Sugiyama | RRBP1 KIAA1398 | SAECQNYAKEVAGLRQLLLEsQSQLDAAKSEAQKQSDELAL |
| Q9UBF8 | T426 | Sugiyama | PI4KB PIK4CB | CENFDTTSVPARIPENRIRstRsVENLPECGItHEQRAGSF |
| Q9UBU9 | S223 | Sugiyama | NXF1 TAP | ELKPEQVEQLKLIMSKRYDGsQQALDLKGLRSDPDLVAQNI |
| Q9UGU0 | S1187 | Sugiyama | TCF20 KIAA0292 SPBP | sDGLPNKGMELKHGSQKLQEsCWDLsRQTsPAKSSGPPGMS |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UIQ6 | S51 | Sugiyama | LNPEP OTASE | AKEPCLHPLEPDEVEyEPRGsRLLVRGLGEHEMEEDEEDyE |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S1542 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDss |
| Q9UQ80 | S383 | Sugiyama | PA2G4 EBP1 | sRKtQKKKKKKAsKtAENAtsGEtLEENEAGD_________ |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2B0 | S178 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NVKDKLCSKRtDLCDHALHIsHDEL________________ |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2I7 | S307 | Sugiyama | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
| Q9Y450 | S67 | Sugiyama | HBS1L HBS1 KIAA1038 | KPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCLDH |
| Q9Y450 | S69 | Sugiyama | HBS1L HBS1 KIAA1038 | sVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCLDHMR |
| Q9Y490 | S1535 | Sugiyama | TLN1 KIAA1027 TLN | RTTNPTAKRQFVQSAKEVANsTANLVKTIKALDGAFTEENR |
| Q9Y4G6 | S1537 | Sugiyama | TLN2 KIAA0320 | KTANPVAKRHFVQSAKEVANsTANLVKTIKALDGDFSEDNR |
| Q9Y6E0 | S400 | Sugiyama | STK24 MST3 STK3 | ISPLFAELKEKsQACGGNLGsIEELRGAIYLAEEACPGISD |
| Q9Y6Y8 | T893 | Sugiyama | SEC23IP MSTP053 | GFISSLKSAWQTLNEFARAHtsstQLQEELEKVANQIKEEE |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 1.035188e-09 | 8.985 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.812493e-08 | 7.055 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.067338e-07 | 6.513 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.529194e-07 | 6.452 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.591819e-07 | 6.181 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.708289e-06 | 5.767 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.123595e-06 | 5.673 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.947438e-06 | 5.404 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.074048e-05 | 4.969 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.319507e-05 | 4.880 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.750057e-05 | 4.757 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.359805e-05 | 4.627 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.359805e-05 | 4.627 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.526190e-05 | 4.598 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.190767e-05 | 4.378 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.124500e-05 | 4.290 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.032450e-05 | 4.220 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.204857e-05 | 4.142 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 9.567029e-05 | 4.019 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.006354e-04 | 3.997 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.056177e-04 | 3.976 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.293143e-04 | 3.888 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.293143e-04 | 3.888 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.218563e-04 | 3.914 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.370959e-04 | 3.863 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.423692e-04 | 3.847 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.802094e-04 | 3.744 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.075260e-04 | 3.683 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.113203e-04 | 3.675 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.094527e-04 | 3.679 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.339394e-04 | 3.631 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.306194e-04 | 3.637 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.342876e-04 | 3.630 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.661973e-04 | 3.575 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.835106e-04 | 3.547 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.025612e-04 | 3.395 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.640048e-04 | 3.333 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.817030e-04 | 3.317 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.069430e-04 | 3.295 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.601845e-04 | 3.252 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.161400e-04 | 3.088 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.776462e-04 | 3.057 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.867458e-04 | 3.052 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.089385e-03 | 2.963 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.111418e-03 | 2.954 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.149404e-03 | 2.940 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.126322e-03 | 2.948 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.471368e-03 | 2.832 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.532192e-03 | 2.815 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.845640e-03 | 2.734 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.845640e-03 | 2.734 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.767218e-03 | 2.753 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.832789e-03 | 2.737 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.832789e-03 | 2.737 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.883011e-03 | 2.725 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.732913e-03 | 2.761 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.772120e-03 | 2.752 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.674283e-03 | 2.776 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.641886e-03 | 2.785 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.780196e-03 | 2.750 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.016687e-03 | 2.695 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.033719e-03 | 2.692 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.090315e-03 | 2.680 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.203816e-03 | 2.657 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.385598e-03 | 2.622 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.320894e-03 | 2.634 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.402751e-03 | 2.619 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.402751e-03 | 2.619 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.430140e-03 | 2.614 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.523186e-03 | 2.598 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.572962e-03 | 2.590 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.724927e-03 | 2.565 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.701462e-03 | 2.568 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.037552e-03 | 2.517 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.189006e-03 | 2.496 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.226254e-03 | 2.491 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.391576e-03 | 2.470 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.437366e-03 | 2.464 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.619222e-03 | 2.441 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.619222e-03 | 2.441 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.619222e-03 | 2.441 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.619222e-03 | 2.441 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.619222e-03 | 2.441 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.481654e-03 | 2.458 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.114905e-03 | 2.386 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.641302e-03 | 2.333 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.757692e-03 | 2.323 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.874973e-03 | 2.312 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.147520e-03 | 2.288 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 5.683873e-03 | 2.245 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.545480e-03 | 2.256 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.545480e-03 | 2.256 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.545480e-03 | 2.256 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.683873e-03 | 2.245 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.339957e-03 | 2.272 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.545480e-03 | 2.256 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.430535e-03 | 2.265 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.679646e-03 | 2.246 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.708624e-03 | 2.243 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.033946e-03 | 2.219 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.083534e-03 | 2.216 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.429246e-03 | 2.192 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.096448e-03 | 2.215 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.432597e-03 | 2.192 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.635025e-03 | 2.178 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.905419e-03 | 2.161 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.905419e-03 | 2.161 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.066702e-03 | 2.151 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.162623e-03 | 2.145 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.495569e-03 | 2.125 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 8.049352e-03 | 2.094 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 8.049352e-03 | 2.094 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.682348e-03 | 2.115 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.165004e-03 | 2.088 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.743733e-03 | 2.058 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.748963e-03 | 2.058 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.198780e-03 | 2.036 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 9.378029e-03 | 2.028 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 9.931343e-03 | 2.003 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.696595e-03 | 2.013 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 9.465552e-03 | 2.024 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.000059e-02 | 2.000 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.119091e-02 | 1.951 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.142034e-02 | 1.942 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.185029e-02 | 1.926 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.026637e-02 | 1.989 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.053609e-02 | 1.977 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.020835e-02 | 1.991 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.187200e-02 | 1.925 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.167663e-02 | 1.933 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.099699e-02 | 1.959 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.162441e-02 | 1.935 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.066495e-02 | 1.972 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.187200e-02 | 1.925 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.207318e-02 | 1.918 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.222334e-02 | 1.913 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.343565e-02 | 1.872 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.303948e-02 | 1.885 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.262656e-02 | 1.899 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.341712e-02 | 1.872 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.330732e-02 | 1.876 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.408120e-02 | 1.851 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.421190e-02 | 1.847 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.461168e-02 | 1.835 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.481396e-02 | 1.829 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.485342e-02 | 1.828 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.500877e-02 | 1.824 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.533768e-02 | 1.814 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.606877e-02 | 1.794 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.606877e-02 | 1.794 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.696611e-02 | 1.770 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.570376e-02 | 1.804 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.582216e-02 | 1.801 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.004171e-02 | 1.698 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.004171e-02 | 1.698 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.004171e-02 | 1.698 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.004171e-02 | 1.698 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.004171e-02 | 1.698 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.004171e-02 | 1.698 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.004171e-02 | 1.698 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.004171e-02 | 1.698 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.004171e-02 | 1.698 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.004171e-02 | 1.698 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.004171e-02 | 1.698 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.857960e-02 | 1.731 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.863000e-02 | 1.730 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.900511e-02 | 1.721 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.857960e-02 | 1.731 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.992435e-02 | 1.701 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.851516e-02 | 1.732 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.956069e-02 | 1.709 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.867898e-02 | 1.729 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.073782e-02 | 1.683 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.074759e-02 | 1.683 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.158111e-02 | 1.666 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.164212e-02 | 1.665 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.214411e-02 | 1.655 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.224223e-02 | 1.653 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.238454e-02 | 1.650 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.238587e-02 | 1.650 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.350360e-02 | 1.629 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.350360e-02 | 1.629 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.430587e-02 | 1.614 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.437253e-02 | 1.613 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.452741e-02 | 1.610 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.455605e-02 | 1.610 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.507077e-02 | 1.601 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.839184e-02 | 1.547 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.614879e-02 | 1.583 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 2.605348e-02 | 1.584 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.839184e-02 | 1.547 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.614879e-02 | 1.583 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.839184e-02 | 1.547 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.614879e-02 | 1.583 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.839870e-02 | 1.547 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.839870e-02 | 1.547 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.856717e-02 | 1.544 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.862138e-02 | 1.543 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 3.342150e-02 | 1.476 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 3.342150e-02 | 1.476 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.978532e-02 | 1.526 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.247153e-02 | 1.488 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.347133e-02 | 1.475 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.997542e-02 | 1.523 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.997542e-02 | 1.523 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.055002e-02 | 1.515 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.059337e-02 | 1.514 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.006019e-02 | 1.522 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.272455e-02 | 1.485 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.207162e-02 | 1.494 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.232615e-02 | 1.490 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.467086e-02 | 1.460 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.467086e-02 | 1.460 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.469936e-02 | 1.460 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.532060e-02 | 1.452 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.568857e-02 | 1.447 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.568857e-02 | 1.447 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.628109e-02 | 1.440 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.670536e-02 | 1.435 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.824671e-02 | 1.417 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.824671e-02 | 1.417 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.972132e-02 | 1.401 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.972132e-02 | 1.401 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.166539e-02 | 1.380 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.327430e-02 | 1.364 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.178220e-02 | 1.379 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.136611e-02 | 1.383 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.117116e-02 | 1.385 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.210668e-02 | 1.376 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.085108e-02 | 1.389 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.210668e-02 | 1.376 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.087385e-02 | 1.389 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.294418e-02 | 1.367 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.294418e-02 | 1.367 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.294418e-02 | 1.367 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.620024e-02 | 1.335 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.972132e-02 | 1.401 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.634786e-02 | 1.334 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.685102e-02 | 1.329 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.792811e-02 | 1.319 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.856443e-02 | 1.314 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.856443e-02 | 1.314 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.856443e-02 | 1.314 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.895400e-02 | 1.310 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.925880e-02 | 1.308 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.925880e-02 | 1.308 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.979952e-02 | 1.303 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.115416e-02 | 1.291 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.115416e-02 | 1.291 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.115416e-02 | 1.291 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.145035e-02 | 1.289 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.145035e-02 | 1.289 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.339684e-02 | 1.272 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.340447e-02 | 1.272 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.511873e-02 | 1.259 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.511873e-02 | 1.259 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 5.590510e-02 | 1.253 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.590510e-02 | 1.253 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.590510e-02 | 1.253 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.499519e-02 | 1.187 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.499519e-02 | 1.187 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.499519e-02 | 1.187 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.640287e-02 | 1.249 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.546897e-02 | 1.256 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.546897e-02 | 1.256 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.052760e-02 | 1.218 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.643747e-02 | 1.248 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.582012e-02 | 1.253 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.248003e-02 | 1.204 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.499519e-02 | 1.187 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.174490e-02 | 1.209 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.208531e-02 | 1.207 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.511873e-02 | 1.259 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.511873e-02 | 1.259 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.590510e-02 | 1.253 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 6.499519e-02 | 1.187 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.371183e-02 | 1.196 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.855323e-02 | 1.232 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.950796e-02 | 1.225 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.499519e-02 | 1.187 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.640287e-02 | 1.249 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.823069e-02 | 1.235 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.965570e-02 | 1.224 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.329370e-02 | 1.199 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.623513e-02 | 1.179 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.837419e-02 | 1.165 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.837419e-02 | 1.165 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.839835e-02 | 1.165 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.846303e-02 | 1.165 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 6.860877e-02 | 1.164 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 6.860877e-02 | 1.164 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.898235e-02 | 1.161 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.186167e-02 | 1.144 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 7.186167e-02 | 1.144 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.354120e-02 | 1.133 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.354120e-02 | 1.133 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.450505e-02 | 1.128 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.532836e-02 | 1.123 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 7.659291e-02 | 1.116 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.708769e-02 | 1.113 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.783305e-02 | 1.109 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.844635e-02 | 1.105 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 7.911134e-02 | 1.102 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 7.911134e-02 | 1.102 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 7.911134e-02 | 1.102 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.978389e-02 | 1.098 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.034191e-02 | 1.095 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.034191e-02 | 1.095 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.034191e-02 | 1.095 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.034191e-02 | 1.095 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.034191e-02 | 1.095 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.034191e-02 | 1.095 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.034191e-02 | 1.095 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.128913e-02 | 1.090 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.190166e-02 | 1.087 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.305068e-02 | 1.081 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.305068e-02 | 1.081 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.068300e-01 | 0.971 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 1.068300e-01 | 0.971 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.068300e-01 | 0.971 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.068300e-01 | 0.971 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 9.364622e-02 | 1.029 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 9.364622e-02 | 1.029 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 9.669910e-02 | 1.015 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 9.669910e-02 | 1.015 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 9.669910e-02 | 1.015 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.383093e-02 | 1.028 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.383093e-02 | 1.028 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.023612e-01 | 0.990 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 9.356337e-02 | 1.029 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.718517e-02 | 1.060 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.872064e-02 | 1.006 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.897340e-02 | 1.051 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.511056e-02 | 1.022 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.030178e-01 | 0.987 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 9.744281e-02 | 1.011 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.554342e-02 | 1.068 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.052933e-01 | 0.978 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 9.159288e-02 | 1.038 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.665814e-02 | 1.015 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 9.364622e-02 | 1.029 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.897340e-02 | 1.051 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 9.383093e-02 | 1.028 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.045499e-01 | 0.981 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.044752e-02 | 1.044 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.023612e-01 | 0.990 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 9.364622e-02 | 1.029 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.043747e-01 | 0.981 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 9.669910e-02 | 1.015 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 9.744281e-02 | 1.011 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 1.078949e-01 | 0.967 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.079594e-01 | 0.967 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.081396e-01 | 0.966 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.085076e-01 | 0.965 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.085076e-01 | 0.965 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.099881e-01 | 0.959 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 1.114135e-01 | 0.953 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.114135e-01 | 0.953 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 1.114135e-01 | 0.953 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.114135e-01 | 0.953 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.114135e-01 | 0.953 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 1.114135e-01 | 0.953 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.128173e-01 | 0.948 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.128173e-01 | 0.948 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.160505e-01 | 0.935 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.160505e-01 | 0.935 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.160505e-01 | 0.935 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.160505e-01 | 0.935 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.160505e-01 | 0.935 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.160505e-01 | 0.935 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.162202e-01 | 0.935 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.166495e-01 | 0.933 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.198411e-01 | 0.921 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.203050e-01 | 0.920 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.206892e-01 | 0.918 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.210763e-01 | 0.917 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.211324e-01 | 0.917 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.211324e-01 | 0.917 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.230167e-01 | 0.910 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.230167e-01 | 0.910 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.249167e-01 | 0.903 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.323488e-01 | 0.878 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.592048e-01 | 0.798 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.592048e-01 | 0.798 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.377260e-01 | 0.861 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.405411e-01 | 0.852 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.405411e-01 | 0.852 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.405411e-01 | 0.852 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.405411e-01 | 0.852 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.405411e-01 | 0.852 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.668743e-01 | 0.778 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.668743e-01 | 0.778 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.365705e-01 | 0.865 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.365705e-01 | 0.865 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.365705e-01 | 0.865 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 1.583690e-01 | 0.800 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.583690e-01 | 0.800 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.487818e-01 | 0.827 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.684757e-01 | 0.773 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.684757e-01 | 0.773 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.298888e-01 | 0.886 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.298888e-01 | 0.886 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.449454e-01 | 0.839 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.449454e-01 | 0.839 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.449454e-01 | 0.839 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.608161e-01 | 0.794 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.608161e-01 | 0.794 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 1.486297e-01 | 0.828 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.486297e-01 | 0.828 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.634495e-01 | 0.787 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.396826e-01 | 0.855 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.301028e-01 | 0.886 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.296158e-01 | 0.887 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.450764e-01 | 0.838 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.486297e-01 | 0.828 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.291403e-01 | 0.889 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.647655e-01 | 0.783 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.513254e-01 | 0.820 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.375632e-01 | 0.861 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 1.391558e-01 | 0.856 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.608161e-01 | 0.794 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.608161e-01 | 0.794 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.684757e-01 | 0.773 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.562624e-01 | 0.806 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.647679e-01 | 0.783 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.352864e-01 | 0.869 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.449454e-01 | 0.839 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.637563e-01 | 0.786 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.592048e-01 | 0.798 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.487818e-01 | 0.827 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.558294e-01 | 0.807 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.583690e-01 | 0.800 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.581499e-01 | 0.801 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.592048e-01 | 0.798 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.592048e-01 | 0.798 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.668743e-01 | 0.778 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.668743e-01 | 0.778 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.583690e-01 | 0.800 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.562624e-01 | 0.806 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.507896e-01 | 0.822 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.538002e-01 | 0.813 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.363007e-01 | 0.866 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.629454e-01 | 0.788 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.375994e-01 | 0.861 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.471881e-01 | 0.607 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.471881e-01 | 0.607 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.471881e-01 | 0.607 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.471881e-01 | 0.607 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.471881e-01 | 0.607 | 0 | 0 |
| TGFBR2 MSI Frameshift Mutants in Cancer | R-HSA-3642279 | 2.471881e-01 | 0.607 | 0 | 0 |
| Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ) | R-HSA-5619088 | 2.471881e-01 | 0.607 | 0 | 0 |
| TWIK-related spinal cord K+ channel (TRESK) | R-HSA-1299344 | 2.471881e-01 | 0.607 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.471881e-01 | 0.607 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.471881e-01 | 0.607 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.471881e-01 | 0.607 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.471881e-01 | 0.607 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.471881e-01 | 0.607 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.099143e-01 | 0.678 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.099143e-01 | 0.678 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.099143e-01 | 0.678 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.099143e-01 | 0.678 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.468334e-01 | 0.460 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.468334e-01 | 0.460 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.468334e-01 | 0.460 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.468334e-01 | 0.460 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.468334e-01 | 0.460 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.468334e-01 | 0.460 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.468334e-01 | 0.460 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.468334e-01 | 0.460 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.468334e-01 | 0.460 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.468334e-01 | 0.460 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.468334e-01 | 0.460 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.468334e-01 | 0.460 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.468334e-01 | 0.460 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.468334e-01 | 0.460 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.468334e-01 | 0.460 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.468334e-01 | 0.460 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.468334e-01 | 0.460 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.468334e-01 | 0.460 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.712173e-01 | 0.766 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.712173e-01 | 0.766 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.712173e-01 | 0.766 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.712173e-01 | 0.766 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.712173e-01 | 0.766 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.619332e-01 | 0.582 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.619332e-01 | 0.582 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.619332e-01 | 0.582 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.619332e-01 | 0.582 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.619332e-01 | 0.582 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.619332e-01 | 0.582 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 2.619332e-01 | 0.582 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 2.619332e-01 | 0.582 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.619332e-01 | 0.582 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 2.619332e-01 | 0.582 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.067219e-01 | 0.685 | 0 | 0 |
| RSK activation | R-HSA-444257 | 2.067219e-01 | 0.685 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.067219e-01 | 0.685 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.947866e-01 | 0.710 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.947866e-01 | 0.710 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.436806e-01 | 0.613 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.436806e-01 | 0.613 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.436806e-01 | 0.613 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 2.436806e-01 | 0.613 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.436806e-01 | 0.613 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.140274e-01 | 0.503 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.140274e-01 | 0.503 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.140274e-01 | 0.503 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.140274e-01 | 0.503 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.140274e-01 | 0.503 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 3.140274e-01 | 0.503 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.332942e-01 | 0.363 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.332942e-01 | 0.363 | 0 | 0 |
| Essential pentosuria | R-HSA-5662853 | 4.332942e-01 | 0.363 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 4.332942e-01 | 0.363 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.332942e-01 | 0.363 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.332942e-01 | 0.363 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.332942e-01 | 0.363 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.332942e-01 | 0.363 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.814739e-01 | 0.741 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.240048e-01 | 0.650 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.240048e-01 | 0.650 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.240048e-01 | 0.650 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.815731e-01 | 0.550 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 2.057314e-01 | 0.687 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.057314e-01 | 0.687 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.057314e-01 | 0.687 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.891898e-01 | 0.723 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.542540e-01 | 0.595 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.652661e-01 | 0.437 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.652661e-01 | 0.437 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.108222e-01 | 0.676 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.108222e-01 | 0.676 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.931353e-01 | 0.714 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.852647e-01 | 0.545 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.852647e-01 | 0.545 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.852647e-01 | 0.545 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.852647e-01 | 0.545 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.570501e-01 | 0.590 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.570501e-01 | 0.590 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.332645e-01 | 0.632 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.948195e-01 | 0.710 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.789401e-01 | 0.747 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.128485e-01 | 0.672 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.330823e-01 | 0.632 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.330823e-01 | 0.632 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.564039e-01 | 0.591 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.837768e-01 | 0.547 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.837768e-01 | 0.547 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.167780e-01 | 0.499 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.583219e-01 | 0.446 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.583219e-01 | 0.446 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.583219e-01 | 0.446 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.583219e-01 | 0.446 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.149634e-01 | 0.382 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.149634e-01 | 0.382 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.149634e-01 | 0.382 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.149634e-01 | 0.382 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 4.149634e-01 | 0.382 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.149634e-01 | 0.382 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.149634e-01 | 0.382 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.149634e-01 | 0.382 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.149634e-01 | 0.382 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.117773e-01 | 0.674 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.314859e-01 | 0.635 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.540124e-01 | 0.595 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.540124e-01 | 0.595 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.801251e-01 | 0.553 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.801251e-01 | 0.553 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.290366e-01 | 0.640 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.290366e-01 | 0.640 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.485498e-01 | 0.458 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.485498e-01 | 0.458 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.485498e-01 | 0.458 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.754688e-01 | 0.560 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.049888e-01 | 0.688 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.043121e-01 | 0.517 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.963932e-01 | 0.402 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.963932e-01 | 0.402 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.963932e-01 | 0.402 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.963932e-01 | 0.402 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.963932e-01 | 0.402 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.803537e-01 | 0.420 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.626298e-01 | 0.335 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.626298e-01 | 0.335 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.626298e-01 | 0.335 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 4.626298e-01 | 0.335 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.626298e-01 | 0.335 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.542105e-01 | 0.595 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.662574e-01 | 0.436 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.662574e-01 | 0.436 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.164372e-01 | 0.665 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.704927e-01 | 0.568 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.899363e-01 | 0.721 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.338293e-01 | 0.363 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.961980e-01 | 0.707 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.104732e-01 | 0.677 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.119834e-01 | 0.385 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.601560e-01 | 0.585 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.785307e-01 | 0.422 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.376447e-01 | 0.624 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.376447e-01 | 0.624 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.492047e-01 | 0.457 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.608495e-01 | 0.443 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.876448e-01 | 0.412 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.876448e-01 | 0.412 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.034599e-01 | 0.394 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.216409e-01 | 0.375 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.703706e-01 | 0.328 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.703706e-01 | 0.328 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.079324e-01 | 0.294 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.079324e-01 | 0.294 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.559532e-01 | 0.449 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.559532e-01 | 0.449 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.677590e-01 | 0.434 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.806077e-01 | 0.420 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.104721e-01 | 0.387 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 4.490426e-01 | 0.348 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.058053e-01 | 0.296 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.058053e-01 | 0.296 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.760941e-01 | 0.322 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.040812e-01 | 0.297 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.690516e-01 | 0.433 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.783477e-01 | 0.320 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.612457e-01 | 0.336 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.026920e-01 | 0.299 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.026920e-01 | 0.299 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.026920e-01 | 0.299 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.026920e-01 | 0.299 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.368307e-01 | 0.360 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.212274e-01 | 0.493 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.005457e-01 | 0.301 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.005457e-01 | 0.301 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.005457e-01 | 0.301 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.654594e-01 | 0.332 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.996775e-01 | 0.301 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.996775e-01 | 0.301 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.982009e-01 | 0.303 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 1.879094e-01 | 0.726 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.323762e-01 | 0.634 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.323762e-01 | 0.634 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.108522e-01 | 0.507 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 2.649964e-01 | 0.577 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.949367e-01 | 0.305 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.944950e-01 | 0.306 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.890213e-01 | 0.723 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.785307e-01 | 0.422 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.479283e-01 | 0.459 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.840490e-01 | 0.547 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.570501e-01 | 0.590 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.910536e-01 | 0.719 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.167780e-01 | 0.499 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.297159e-01 | 0.367 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.297159e-01 | 0.367 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.583219e-01 | 0.446 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.192369e-01 | 0.659 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.865119e-01 | 0.543 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.920166e-01 | 0.407 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.453096e-01 | 0.462 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.804853e-01 | 0.318 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.294645e-01 | 0.639 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.297159e-01 | 0.367 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.726345e-01 | 0.763 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.738453e-01 | 0.562 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.948007e-01 | 0.530 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.815731e-01 | 0.550 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.583219e-01 | 0.446 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.374583e-01 | 0.624 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.852647e-01 | 0.545 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.099566e-01 | 0.678 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.338293e-01 | 0.363 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 4.332456e-01 | 0.363 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.507351e-01 | 0.455 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.815731e-01 | 0.550 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.309790e-01 | 0.636 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.946251e-01 | 0.531 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.384477e-01 | 0.471 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.216409e-01 | 0.375 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.025327e-01 | 0.519 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.314859e-01 | 0.635 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.294642e-01 | 0.367 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.947866e-01 | 0.710 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.159161e-01 | 0.381 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.316078e-01 | 0.635 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 2.436806e-01 | 0.613 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.140274e-01 | 0.503 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.815731e-01 | 0.550 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.815731e-01 | 0.550 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.774573e-01 | 0.751 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.338293e-01 | 0.363 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.421363e-01 | 0.466 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.703706e-01 | 0.328 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.740003e-01 | 0.324 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.005457e-01 | 0.301 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.999853e-01 | 0.699 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.238792e-01 | 0.373 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.412149e-01 | 0.467 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.876448e-01 | 0.412 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.542540e-01 | 0.595 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.128485e-01 | 0.672 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.738453e-01 | 0.562 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 2.067219e-01 | 0.685 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.099143e-01 | 0.678 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 1.712173e-01 | 0.766 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.619332e-01 | 0.582 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.067219e-01 | 0.685 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.947866e-01 | 0.710 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.652661e-01 | 0.437 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.788147e-01 | 0.748 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.963932e-01 | 0.402 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.940038e-01 | 0.404 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.294642e-01 | 0.367 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.099269e-01 | 0.387 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.948195e-01 | 0.710 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.104732e-01 | 0.677 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.268946e-01 | 0.370 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.043121e-01 | 0.517 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.924054e-01 | 0.716 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.492047e-01 | 0.457 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.652661e-01 | 0.437 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.288500e-01 | 0.483 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.662574e-01 | 0.436 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 4.338293e-01 | 0.363 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.595936e-01 | 0.586 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.452965e-01 | 0.610 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.760941e-01 | 0.322 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.899363e-01 | 0.721 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.918591e-01 | 0.308 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.436806e-01 | 0.613 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.436806e-01 | 0.613 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.140274e-01 | 0.503 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.542540e-01 | 0.595 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.314859e-01 | 0.635 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.540124e-01 | 0.595 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.485498e-01 | 0.458 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.803537e-01 | 0.420 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 5.079324e-01 | 0.294 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.058053e-01 | 0.296 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.040812e-01 | 0.297 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.982009e-01 | 0.303 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.982009e-01 | 0.303 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.982009e-01 | 0.303 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.982009e-01 | 0.303 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.485498e-01 | 0.458 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.421363e-01 | 0.466 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.154047e-01 | 0.382 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 3.043121e-01 | 0.517 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.969639e-01 | 0.304 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.514136e-01 | 0.345 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.703706e-01 | 0.328 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.026920e-01 | 0.299 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.957112e-01 | 0.708 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.058053e-01 | 0.296 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.240465e-01 | 0.373 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.955073e-01 | 0.403 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.099143e-01 | 0.678 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.542540e-01 | 0.595 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.948195e-01 | 0.710 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.149634e-01 | 0.382 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.119834e-01 | 0.385 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.044359e-01 | 0.393 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.217578e-01 | 0.492 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.793518e-01 | 0.554 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.904197e-01 | 0.537 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.119834e-01 | 0.385 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.216409e-01 | 0.375 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.466110e-01 | 0.608 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.067219e-01 | 0.685 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.652661e-01 | 0.437 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.789401e-01 | 0.747 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.196168e-01 | 0.495 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.735733e-01 | 0.428 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.432536e-01 | 0.353 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.220528e-01 | 0.654 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.079324e-01 | 0.294 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.039699e-01 | 0.690 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.058053e-01 | 0.296 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.190657e-01 | 0.496 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.801251e-01 | 0.553 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.196168e-01 | 0.495 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.909748e-01 | 0.408 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.329458e-01 | 0.633 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.453096e-01 | 0.462 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.471881e-01 | 0.607 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.468334e-01 | 0.460 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.468334e-01 | 0.460 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 2.067219e-01 | 0.685 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.140274e-01 | 0.503 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.140274e-01 | 0.503 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.332942e-01 | 0.363 | 0 | 0 |
| Influenza Virus Induced Apoptosis | R-HSA-168277 | 4.332942e-01 | 0.363 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.332942e-01 | 0.363 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.332942e-01 | 0.363 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.332942e-01 | 0.363 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.332942e-01 | 0.363 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.240048e-01 | 0.650 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.950633e-01 | 0.710 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.167780e-01 | 0.499 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.149634e-01 | 0.382 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 4.149634e-01 | 0.382 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.703366e-01 | 0.568 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 3.385385e-01 | 0.470 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.626298e-01 | 0.335 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.536259e-01 | 0.451 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.648397e-01 | 0.438 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 4.703706e-01 | 0.328 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 4.703706e-01 | 0.328 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 5.079324e-01 | 0.294 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.079324e-01 | 0.294 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.760941e-01 | 0.322 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.268946e-01 | 0.370 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.789917e-01 | 0.320 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.461013e-01 | 0.461 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.578775e-01 | 0.339 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.372790e-01 | 0.625 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.703706e-01 | 0.328 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.376447e-01 | 0.624 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.256230e-01 | 0.487 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.040812e-01 | 0.297 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.982009e-01 | 0.303 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.763414e-01 | 0.754 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.119681e-01 | 0.385 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.049888e-01 | 0.688 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.079324e-01 | 0.294 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.290366e-01 | 0.640 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.754688e-01 | 0.560 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.943507e-01 | 0.711 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.199268e-01 | 0.495 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.943507e-01 | 0.711 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.192369e-01 | 0.659 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.942246e-01 | 0.306 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.432536e-01 | 0.353 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.385385e-01 | 0.470 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.196168e-01 | 0.495 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.004366e-01 | 0.397 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.841917e-01 | 0.415 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.958510e-01 | 0.529 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 2.619332e-01 | 0.582 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.436806e-01 | 0.613 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.140274e-01 | 0.503 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.128485e-01 | 0.672 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.837768e-01 | 0.547 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.633627e-01 | 0.334 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 4.982009e-01 | 0.303 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.412149e-01 | 0.467 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.703706e-01 | 0.328 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.989026e-01 | 0.302 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.940216e-01 | 0.532 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.260585e-01 | 0.646 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.104721e-01 | 0.387 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.468334e-01 | 0.460 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.468334e-01 | 0.460 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.140274e-01 | 0.503 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.309790e-01 | 0.636 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.199268e-01 | 0.495 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.332645e-01 | 0.632 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.948195e-01 | 0.710 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.963932e-01 | 0.402 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.338293e-01 | 0.363 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 5.079324e-01 | 0.294 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.104721e-01 | 0.387 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.530017e-01 | 0.344 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.530017e-01 | 0.344 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.104721e-01 | 0.387 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.740003e-01 | 0.324 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.652661e-01 | 0.437 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.314859e-01 | 0.635 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.196168e-01 | 0.495 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.119834e-01 | 0.385 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 4.703706e-01 | 0.328 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.026920e-01 | 0.299 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.814739e-01 | 0.741 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.058053e-01 | 0.296 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.058053e-01 | 0.296 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.619332e-01 | 0.582 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.332942e-01 | 0.363 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.149634e-01 | 0.382 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 4.149634e-01 | 0.382 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.626298e-01 | 0.335 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.735733e-01 | 0.428 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.079324e-01 | 0.294 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.043121e-01 | 0.517 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 4.703706e-01 | 0.328 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.337199e-01 | 0.363 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 2.769440e-01 | 0.558 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.079324e-01 | 0.294 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.140274e-01 | 0.503 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.891898e-01 | 0.723 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.199268e-01 | 0.495 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.149634e-01 | 0.382 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.626298e-01 | 0.335 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.626298e-01 | 0.335 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.079324e-01 | 0.294 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.058053e-01 | 0.296 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.058053e-01 | 0.296 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.996775e-01 | 0.301 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.207224e-01 | 0.656 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.846336e-01 | 0.315 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.315666e-01 | 0.479 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 5.079324e-01 | 0.294 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 4.703706e-01 | 0.328 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 5.079324e-01 | 0.294 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 3.662574e-01 | 0.436 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 4.119834e-01 | 0.385 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.083144e-01 | 0.294 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.083144e-01 | 0.294 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.083144e-01 | 0.294 | 0 | 0 |
| Defective CYP7B1 causes SPG5A and CBAS3 | R-HSA-5579013 | 5.083144e-01 | 0.294 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.083144e-01 | 0.294 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.083144e-01 | 0.294 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.083144e-01 | 0.294 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 5.083144e-01 | 0.294 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.083144e-01 | 0.294 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 5.083144e-01 | 0.294 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.083144e-01 | 0.294 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.083144e-01 | 0.294 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.102472e-01 | 0.292 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.112631e-01 | 0.291 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.123692e-01 | 0.290 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.129743e-01 | 0.290 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.135831e-01 | 0.289 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.144636e-01 | 0.289 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.149275e-01 | 0.288 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.164328e-01 | 0.287 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.199587e-01 | 0.284 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.235814e-01 | 0.281 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.249850e-01 | 0.280 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.252324e-01 | 0.280 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.273625e-01 | 0.278 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.287449e-01 | 0.277 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.287449e-01 | 0.277 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.287449e-01 | 0.277 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.287449e-01 | 0.277 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.287449e-01 | 0.277 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.287449e-01 | 0.277 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.290192e-01 | 0.277 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.333748e-01 | 0.273 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.333748e-01 | 0.273 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.344561e-01 | 0.272 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.344561e-01 | 0.272 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.399661e-01 | 0.268 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.399661e-01 | 0.268 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.399661e-01 | 0.268 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.439452e-01 | 0.264 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.442152e-01 | 0.264 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.506617e-01 | 0.259 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.506617e-01 | 0.259 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 5.506617e-01 | 0.259 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 5.506617e-01 | 0.259 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.506617e-01 | 0.259 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.506617e-01 | 0.259 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.506617e-01 | 0.259 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.506617e-01 | 0.259 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 5.506617e-01 | 0.259 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 5.506617e-01 | 0.259 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.506617e-01 | 0.259 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.536492e-01 | 0.257 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.540640e-01 | 0.256 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.541729e-01 | 0.256 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.541729e-01 | 0.256 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.558415e-01 | 0.255 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.593391e-01 | 0.252 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.596933e-01 | 0.252 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.600429e-01 | 0.252 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.600429e-01 | 0.252 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.600429e-01 | 0.252 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.606549e-01 | 0.251 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.617799e-01 | 0.250 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.617799e-01 | 0.250 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.650457e-01 | 0.248 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.650457e-01 | 0.248 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.658534e-01 | 0.247 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.697554e-01 | 0.244 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.711619e-01 | 0.243 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.725843e-01 | 0.242 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.727254e-01 | 0.242 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.727254e-01 | 0.242 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.727254e-01 | 0.242 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.727254e-01 | 0.242 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.734073e-01 | 0.242 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.734073e-01 | 0.242 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.734073e-01 | 0.242 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.734073e-01 | 0.242 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 5.734073e-01 | 0.242 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 5.734073e-01 | 0.242 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.734073e-01 | 0.242 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.734073e-01 | 0.242 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.734073e-01 | 0.242 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.734073e-01 | 0.242 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.734073e-01 | 0.242 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.734073e-01 | 0.242 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.734073e-01 | 0.242 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 5.734073e-01 | 0.242 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.747538e-01 | 0.241 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.789074e-01 | 0.237 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.793804e-01 | 0.237 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.793804e-01 | 0.237 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.793804e-01 | 0.237 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.823494e-01 | 0.235 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.856880e-01 | 0.232 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.856880e-01 | 0.232 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.859229e-01 | 0.232 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.867242e-01 | 0.232 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 5.892139e-01 | 0.230 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 5.892139e-01 | 0.230 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.896918e-01 | 0.229 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.907051e-01 | 0.229 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.907051e-01 | 0.229 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.907051e-01 | 0.229 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.907051e-01 | 0.229 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.907051e-01 | 0.229 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 5.907051e-01 | 0.229 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.907051e-01 | 0.229 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.985677e-01 | 0.223 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.025035e-01 | 0.220 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.025951e-01 | 0.220 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.028909e-01 | 0.220 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.028909e-01 | 0.220 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.039910e-01 | 0.219 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.058345e-01 | 0.218 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.058345e-01 | 0.218 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.058701e-01 | 0.218 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.099662e-01 | 0.215 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.099662e-01 | 0.215 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.141971e-01 | 0.212 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.144883e-01 | 0.211 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.147969e-01 | 0.211 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.147969e-01 | 0.211 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.156122e-01 | 0.211 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.156122e-01 | 0.211 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.170514e-01 | 0.210 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.194686e-01 | 0.208 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.218385e-01 | 0.206 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.218385e-01 | 0.206 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.260762e-01 | 0.203 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.260762e-01 | 0.203 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.280249e-01 | 0.202 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.280249e-01 | 0.202 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.280249e-01 | 0.202 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.280249e-01 | 0.202 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 6.287701e-01 | 0.202 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.290289e-01 | 0.201 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.298859e-01 | 0.201 | 0 | 0 |
| Defective CYP17A1 causes AH5 | R-HSA-5579028 | 6.298859e-01 | 0.201 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.298859e-01 | 0.201 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.298859e-01 | 0.201 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.298859e-01 | 0.201 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.298859e-01 | 0.201 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 6.298859e-01 | 0.201 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.298859e-01 | 0.201 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 6.298859e-01 | 0.201 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.298859e-01 | 0.201 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.298859e-01 | 0.201 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.298859e-01 | 0.201 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 6.298859e-01 | 0.201 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.300929e-01 | 0.201 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.324292e-01 | 0.199 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.337017e-01 | 0.198 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.337017e-01 | 0.198 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.337017e-01 | 0.198 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 6.337017e-01 | 0.198 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.351613e-01 | 0.197 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.351613e-01 | 0.197 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.365092e-01 | 0.196 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.368590e-01 | 0.196 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.406729e-01 | 0.193 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.419879e-01 | 0.192 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.441200e-01 | 0.191 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.441200e-01 | 0.191 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.441200e-01 | 0.191 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.445137e-01 | 0.191 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.484259e-01 | 0.188 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.484259e-01 | 0.188 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.484259e-01 | 0.188 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.484259e-01 | 0.188 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.524638e-01 | 0.185 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.535321e-01 | 0.185 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.558241e-01 | 0.183 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.558241e-01 | 0.183 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.558241e-01 | 0.183 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.602711e-01 | 0.180 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.612217e-01 | 0.180 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.618232e-01 | 0.179 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.618232e-01 | 0.179 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.618232e-01 | 0.179 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.618232e-01 | 0.179 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.618232e-01 | 0.179 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.618232e-01 | 0.179 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.618232e-01 | 0.179 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.618232e-01 | 0.179 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.618232e-01 | 0.179 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.626403e-01 | 0.179 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 6.626403e-01 | 0.179 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.626403e-01 | 0.179 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.626403e-01 | 0.179 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.626403e-01 | 0.179 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 6.626403e-01 | 0.179 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 6.626403e-01 | 0.179 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.629955e-01 | 0.178 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.695275e-01 | 0.174 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.698181e-01 | 0.174 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.699120e-01 | 0.174 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.715223e-01 | 0.173 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.752907e-01 | 0.171 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.763268e-01 | 0.170 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.788899e-01 | 0.168 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.788899e-01 | 0.168 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.788899e-01 | 0.168 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.788899e-01 | 0.168 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.788899e-01 | 0.168 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.788899e-01 | 0.168 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.788899e-01 | 0.168 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.788899e-01 | 0.168 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.788899e-01 | 0.168 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.788899e-01 | 0.168 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.788899e-01 | 0.168 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.788899e-01 | 0.168 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.788899e-01 | 0.168 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.788899e-01 | 0.168 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.788899e-01 | 0.168 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.788899e-01 | 0.168 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.788899e-01 | 0.168 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.788899e-01 | 0.168 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.788899e-01 | 0.168 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.788899e-01 | 0.168 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.788899e-01 | 0.168 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.788899e-01 | 0.168 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 6.798517e-01 | 0.168 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.813166e-01 | 0.167 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.864994e-01 | 0.163 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.881780e-01 | 0.162 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.881780e-01 | 0.162 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.881780e-01 | 0.162 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.881780e-01 | 0.162 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.883437e-01 | 0.162 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 6.883437e-01 | 0.162 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 6.883437e-01 | 0.162 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.883437e-01 | 0.162 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.890529e-01 | 0.162 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.905147e-01 | 0.161 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.905147e-01 | 0.161 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.905147e-01 | 0.161 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.905147e-01 | 0.161 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.905147e-01 | 0.161 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.905147e-01 | 0.161 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.912828e-01 | 0.160 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.920641e-01 | 0.160 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.940347e-01 | 0.159 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.940347e-01 | 0.159 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.946132e-01 | 0.158 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 6.946132e-01 | 0.158 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 6.946132e-01 | 0.158 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.946132e-01 | 0.158 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.946132e-01 | 0.158 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.946132e-01 | 0.158 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 6.946132e-01 | 0.158 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.100866e-01 | 0.149 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.100866e-01 | 0.149 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.102220e-01 | 0.149 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.120443e-01 | 0.147 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.132710e-01 | 0.147 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.132710e-01 | 0.147 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.132710e-01 | 0.147 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.132710e-01 | 0.147 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.132710e-01 | 0.147 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.162987e-01 | 0.145 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.180851e-01 | 0.144 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.214081e-01 | 0.142 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.214081e-01 | 0.142 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.214081e-01 | 0.142 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 7.214081e-01 | 0.142 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 7.214081e-01 | 0.142 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.214081e-01 | 0.142 | 0 | 0 |
| Defective CYP11A1 causes AICSR | R-HSA-5579026 | 7.214081e-01 | 0.142 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 7.214081e-01 | 0.142 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.214081e-01 | 0.142 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 7.214081e-01 | 0.142 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.214081e-01 | 0.142 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.214081e-01 | 0.142 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 7.214081e-01 | 0.142 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.214081e-01 | 0.142 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.240363e-01 | 0.140 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 7.240363e-01 | 0.140 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.240363e-01 | 0.140 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.240363e-01 | 0.140 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.240363e-01 | 0.140 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.240363e-01 | 0.140 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.253228e-01 | 0.139 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.290289e-01 | 0.137 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.290289e-01 | 0.137 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.297273e-01 | 0.137 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.308486e-01 | 0.136 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.308486e-01 | 0.136 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.308486e-01 | 0.136 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.308486e-01 | 0.136 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.357691e-01 | 0.133 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.366284e-01 | 0.133 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.366284e-01 | 0.133 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.366284e-01 | 0.133 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.366284e-01 | 0.133 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.371633e-01 | 0.132 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.382838e-01 | 0.132 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.449210e-01 | 0.128 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.458384e-01 | 0.127 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.469366e-01 | 0.127 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.469366e-01 | 0.127 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.504744e-01 | 0.125 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.504744e-01 | 0.125 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.510243e-01 | 0.124 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.510243e-01 | 0.124 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.510243e-01 | 0.124 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.510243e-01 | 0.124 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.510243e-01 | 0.124 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.510243e-01 | 0.124 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.510243e-01 | 0.124 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.510243e-01 | 0.124 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 7.510243e-01 | 0.124 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.521644e-01 | 0.124 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.542128e-01 | 0.123 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.582986e-01 | 0.120 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.582986e-01 | 0.120 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.582986e-01 | 0.120 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 7.582986e-01 | 0.120 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.582986e-01 | 0.120 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.582986e-01 | 0.120 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.582986e-01 | 0.120 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.582986e-01 | 0.120 | 0 | 0 |
| Electron transport from NADPH to Ferredoxin | R-HSA-2395516 | 7.582986e-01 | 0.120 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.582986e-01 | 0.120 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.582986e-01 | 0.120 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.582986e-01 | 0.120 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.584524e-01 | 0.120 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.584524e-01 | 0.120 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.584524e-01 | 0.120 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.584524e-01 | 0.120 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.584524e-01 | 0.120 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.598309e-01 | 0.119 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.609492e-01 | 0.119 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.609492e-01 | 0.119 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.616229e-01 | 0.118 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.627083e-01 | 0.118 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.639521e-01 | 0.117 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.640123e-01 | 0.117 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.669274e-01 | 0.115 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.689817e-01 | 0.114 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.746634e-01 | 0.111 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.750787e-01 | 0.111 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.757061e-01 | 0.110 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.757061e-01 | 0.110 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.757061e-01 | 0.110 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.757061e-01 | 0.110 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 7.757061e-01 | 0.110 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.757061e-01 | 0.110 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.757061e-01 | 0.110 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.757061e-01 | 0.110 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.757061e-01 | 0.110 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 7.757061e-01 | 0.110 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.757061e-01 | 0.110 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.757061e-01 | 0.110 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.787895e-01 | 0.109 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.800869e-01 | 0.108 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.832390e-01 | 0.106 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.863950e-01 | 0.104 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.863950e-01 | 0.104 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.885640e-01 | 0.103 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.885640e-01 | 0.103 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.897656e-01 | 0.103 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.903060e-01 | 0.102 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.903060e-01 | 0.102 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.903060e-01 | 0.102 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.903060e-01 | 0.102 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.903060e-01 | 0.102 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.903060e-01 | 0.102 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.903060e-01 | 0.102 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.903060e-01 | 0.102 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.903060e-01 | 0.102 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.903060e-01 | 0.102 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.903060e-01 | 0.102 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.903060e-01 | 0.102 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.903060e-01 | 0.102 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.903060e-01 | 0.102 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.903060e-01 | 0.102 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.903060e-01 | 0.102 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.903060e-01 | 0.102 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.919179e-01 | 0.101 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.920048e-01 | 0.101 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.929918e-01 | 0.101 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.953569e-01 | 0.099 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.968372e-01 | 0.099 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.976942e-01 | 0.098 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.976942e-01 | 0.098 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.976942e-01 | 0.098 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 7.976942e-01 | 0.098 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.976942e-01 | 0.098 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.982191e-01 | 0.098 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.982191e-01 | 0.098 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.982191e-01 | 0.098 | 0 | 0 |
| Formation of xylulose-5-phosphate | R-HSA-5661270 | 7.982191e-01 | 0.098 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 7.982191e-01 | 0.098 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 7.982191e-01 | 0.098 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.999655e-01 | 0.097 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.004201e-01 | 0.097 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.010811e-01 | 0.096 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.027437e-01 | 0.095 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.046036e-01 | 0.094 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.046036e-01 | 0.094 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.076555e-01 | 0.093 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.097817e-01 | 0.092 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.097817e-01 | 0.092 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.097817e-01 | 0.092 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.099996e-01 | 0.092 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.115526e-01 | 0.091 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.150421e-01 | 0.089 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.152269e-01 | 0.089 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.152269e-01 | 0.089 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.172384e-01 | 0.088 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.180618e-01 | 0.087 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.180618e-01 | 0.087 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.180764e-01 | 0.087 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.180764e-01 | 0.087 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 8.180764e-01 | 0.087 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 8.180764e-01 | 0.087 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 8.180764e-01 | 0.087 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.180764e-01 | 0.087 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 8.180764e-01 | 0.087 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.187047e-01 | 0.087 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.187047e-01 | 0.087 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.187047e-01 | 0.087 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.187047e-01 | 0.087 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.187047e-01 | 0.087 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.196777e-01 | 0.086 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.233667e-01 | 0.084 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.284781e-01 | 0.082 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.297385e-01 | 0.081 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.309047e-01 | 0.080 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.313375e-01 | 0.080 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.314519e-01 | 0.080 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.314519e-01 | 0.080 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.328504e-01 | 0.079 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.361882e-01 | 0.078 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.361882e-01 | 0.078 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 8.371606e-01 | 0.077 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.373051e-01 | 0.077 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.373051e-01 | 0.077 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.373051e-01 | 0.077 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.373051e-01 | 0.077 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.373051e-01 | 0.077 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.406675e-01 | 0.075 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.413000e-01 | 0.075 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.421705e-01 | 0.075 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.421705e-01 | 0.075 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.421705e-01 | 0.075 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.421705e-01 | 0.075 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.421705e-01 | 0.075 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 8.421705e-01 | 0.075 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.421705e-01 | 0.075 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.421705e-01 | 0.075 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.421705e-01 | 0.075 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.421705e-01 | 0.075 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.421705e-01 | 0.075 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.421705e-01 | 0.075 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.421705e-01 | 0.075 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.464365e-01 | 0.072 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.464365e-01 | 0.072 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.470000e-01 | 0.072 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.522171e-01 | 0.069 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.522171e-01 | 0.069 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.522171e-01 | 0.069 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.541601e-01 | 0.068 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.541601e-01 | 0.068 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.541601e-01 | 0.068 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.541601e-01 | 0.068 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.541601e-01 | 0.068 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.541601e-01 | 0.068 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 8.569715e-01 | 0.067 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.582170e-01 | 0.066 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.582170e-01 | 0.066 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.595134e-01 | 0.066 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.602491e-01 | 0.065 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.602491e-01 | 0.065 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.602491e-01 | 0.065 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.625110e-01 | 0.064 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.627885e-01 | 0.064 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.630748e-01 | 0.064 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.630748e-01 | 0.064 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.630748e-01 | 0.064 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.630748e-01 | 0.064 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.630748e-01 | 0.064 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.630748e-01 | 0.064 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.630748e-01 | 0.064 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.630748e-01 | 0.064 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.630748e-01 | 0.064 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.630748e-01 | 0.064 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.630748e-01 | 0.064 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.630748e-01 | 0.064 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.655064e-01 | 0.063 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.664078e-01 | 0.062 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.664078e-01 | 0.062 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.671762e-01 | 0.062 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.694057e-01 | 0.061 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.694057e-01 | 0.061 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.694057e-01 | 0.061 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.698072e-01 | 0.061 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.700925e-01 | 0.060 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.700925e-01 | 0.060 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.700925e-01 | 0.060 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.700925e-01 | 0.060 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.700925e-01 | 0.060 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.707712e-01 | 0.060 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.707712e-01 | 0.060 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.707712e-01 | 0.060 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.707712e-01 | 0.060 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.722040e-01 | 0.059 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.724656e-01 | 0.059 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.729587e-01 | 0.059 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.753536e-01 | 0.058 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.790098e-01 | 0.056 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.805717e-01 | 0.055 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.812113e-01 | 0.055 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.812113e-01 | 0.055 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.812113e-01 | 0.055 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.812113e-01 | 0.055 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.812113e-01 | 0.055 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.812113e-01 | 0.055 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.831725e-01 | 0.054 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.831725e-01 | 0.054 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.831725e-01 | 0.054 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.846335e-01 | 0.053 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.892358e-01 | 0.051 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.898795e-01 | 0.051 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.905541e-01 | 0.050 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.905541e-01 | 0.050 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.929277e-01 | 0.049 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.938622e-01 | 0.049 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.941874e-01 | 0.049 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.953407e-01 | 0.048 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.955847e-01 | 0.048 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.955847e-01 | 0.048 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.955847e-01 | 0.048 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.969465e-01 | 0.047 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.969465e-01 | 0.047 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.969465e-01 | 0.047 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.969465e-01 | 0.047 | 0 | 0 |
| Proline catabolism | R-HSA-70688 | 8.969465e-01 | 0.047 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.969465e-01 | 0.047 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.969465e-01 | 0.047 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.969465e-01 | 0.047 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.969465e-01 | 0.047 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.969465e-01 | 0.047 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.969465e-01 | 0.047 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.969465e-01 | 0.047 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.969465e-01 | 0.047 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.002472e-01 | 0.046 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.054317e-01 | 0.043 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.067595e-01 | 0.043 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.067595e-01 | 0.043 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.067595e-01 | 0.043 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.067595e-01 | 0.043 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.067595e-01 | 0.043 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.067595e-01 | 0.043 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.067595e-01 | 0.043 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.083454e-01 | 0.042 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 9.105982e-01 | 0.041 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 9.105982e-01 | 0.041 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.105982e-01 | 0.041 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 9.105982e-01 | 0.041 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 9.105982e-01 | 0.041 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 9.105982e-01 | 0.041 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 9.105982e-01 | 0.041 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 9.105982e-01 | 0.041 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 9.105982e-01 | 0.041 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.105982e-01 | 0.041 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 9.105982e-01 | 0.041 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 9.105982e-01 | 0.041 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.105982e-01 | 0.041 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.124709e-01 | 0.040 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.124709e-01 | 0.040 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.128017e-01 | 0.040 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.133787e-01 | 0.039 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.162388e-01 | 0.038 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.168068e-01 | 0.038 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.168068e-01 | 0.038 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.168068e-01 | 0.038 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.168068e-01 | 0.038 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.168068e-01 | 0.038 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.190504e-01 | 0.037 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.197789e-01 | 0.036 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.204201e-01 | 0.036 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.221377e-01 | 0.035 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.222988e-01 | 0.035 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.224420e-01 | 0.035 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 9.224420e-01 | 0.035 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.224420e-01 | 0.035 | 0 | 0 |
| Transport of fatty acids | R-HSA-804914 | 9.224420e-01 | 0.035 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.224420e-01 | 0.035 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 9.224420e-01 | 0.035 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.224420e-01 | 0.035 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.227899e-01 | 0.035 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.242088e-01 | 0.034 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.251934e-01 | 0.034 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.258293e-01 | 0.033 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.258293e-01 | 0.033 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.267834e-01 | 0.033 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.267834e-01 | 0.033 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.267834e-01 | 0.033 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.293610e-01 | 0.032 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.297658e-01 | 0.032 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.297658e-01 | 0.032 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.297658e-01 | 0.032 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.302246e-01 | 0.031 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.327174e-01 | 0.030 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.327174e-01 | 0.030 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.327174e-01 | 0.030 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 9.327174e-01 | 0.030 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 9.327174e-01 | 0.030 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.327174e-01 | 0.030 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 9.327174e-01 | 0.030 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.327174e-01 | 0.030 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.327174e-01 | 0.030 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.327174e-01 | 0.030 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.327673e-01 | 0.030 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.339220e-01 | 0.030 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.339220e-01 | 0.030 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.339220e-01 | 0.030 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.339220e-01 | 0.030 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.339220e-01 | 0.030 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.339220e-01 | 0.030 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.363943e-01 | 0.029 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.383100e-01 | 0.028 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.401275e-01 | 0.027 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.411729e-01 | 0.026 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.411729e-01 | 0.026 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.411729e-01 | 0.026 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.416320e-01 | 0.026 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.416320e-01 | 0.026 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.416320e-01 | 0.026 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.416320e-01 | 0.026 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 9.416320e-01 | 0.026 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.416320e-01 | 0.026 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.416320e-01 | 0.026 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.416320e-01 | 0.026 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.416320e-01 | 0.026 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.427554e-01 | 0.026 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.427554e-01 | 0.026 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.427554e-01 | 0.026 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.427554e-01 | 0.026 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.427554e-01 | 0.026 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.434384e-01 | 0.025 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.441222e-01 | 0.025 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.446980e-01 | 0.025 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.459396e-01 | 0.024 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.472692e-01 | 0.024 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.476630e-01 | 0.023 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.476630e-01 | 0.023 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.476630e-01 | 0.023 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.476630e-01 | 0.023 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.476630e-01 | 0.023 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.481787e-01 | 0.023 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.483792e-01 | 0.023 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.483792e-01 | 0.023 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.489809e-01 | 0.023 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.493659e-01 | 0.023 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.493659e-01 | 0.023 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.493659e-01 | 0.023 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.493659e-01 | 0.023 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.493659e-01 | 0.023 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.493659e-01 | 0.023 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 9.493659e-01 | 0.023 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.493659e-01 | 0.023 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.493659e-01 | 0.023 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.520423e-01 | 0.021 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.520423e-01 | 0.021 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.526321e-01 | 0.021 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.534665e-01 | 0.021 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.534846e-01 | 0.021 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.553676e-01 | 0.020 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.559812e-01 | 0.020 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.560754e-01 | 0.020 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.560754e-01 | 0.020 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.560754e-01 | 0.020 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.560754e-01 | 0.020 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.560754e-01 | 0.020 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.581148e-01 | 0.019 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.586514e-01 | 0.018 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.603151e-01 | 0.018 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.605444e-01 | 0.017 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.618961e-01 | 0.017 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.618961e-01 | 0.017 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.618961e-01 | 0.017 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.618961e-01 | 0.017 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.618961e-01 | 0.017 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.623098e-01 | 0.017 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.623098e-01 | 0.017 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.623098e-01 | 0.017 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.623098e-01 | 0.017 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.623098e-01 | 0.017 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.632797e-01 | 0.016 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.644002e-01 | 0.016 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.644002e-01 | 0.016 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.661071e-01 | 0.015 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.661071e-01 | 0.015 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.669459e-01 | 0.015 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.669459e-01 | 0.015 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.669459e-01 | 0.015 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.669459e-01 | 0.015 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.669459e-01 | 0.015 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.673282e-01 | 0.014 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.674078e-01 | 0.014 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.674078e-01 | 0.014 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.679410e-01 | 0.014 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.695411e-01 | 0.013 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.695411e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.695411e-01 | 0.013 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.695635e-01 | 0.013 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.700571e-01 | 0.013 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.713266e-01 | 0.013 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.713266e-01 | 0.013 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.713266e-01 | 0.013 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.713266e-01 | 0.013 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.713266e-01 | 0.013 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.713266e-01 | 0.013 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.719801e-01 | 0.012 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.726441e-01 | 0.012 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.726441e-01 | 0.012 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.726441e-01 | 0.012 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.738692e-01 | 0.011 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.743637e-01 | 0.011 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.751270e-01 | 0.011 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.751270e-01 | 0.011 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.751270e-01 | 0.011 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.751270e-01 | 0.011 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.751270e-01 | 0.011 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.752865e-01 | 0.011 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.757844e-01 | 0.011 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.761155e-01 | 0.010 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.771337e-01 | 0.010 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.772800e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.772800e-01 | 0.010 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.772800e-01 | 0.010 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.778580e-01 | 0.010 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.784239e-01 | 0.009 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.784239e-01 | 0.009 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.784239e-01 | 0.009 | 0 | 0 |
| Glucocorticoid biosynthesis | R-HSA-194002 | 9.784239e-01 | 0.009 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.784239e-01 | 0.009 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.784239e-01 | 0.009 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.784239e-01 | 0.009 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.798738e-01 | 0.009 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.798738e-01 | 0.009 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.798738e-01 | 0.009 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.802512e-01 | 0.009 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.802512e-01 | 0.009 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.802512e-01 | 0.009 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.804235e-01 | 0.009 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.807205e-01 | 0.008 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.810635e-01 | 0.008 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.812839e-01 | 0.008 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.812839e-01 | 0.008 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.812839e-01 | 0.008 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.821794e-01 | 0.008 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.821794e-01 | 0.008 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.821794e-01 | 0.008 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.821794e-01 | 0.008 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.823034e-01 | 0.008 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.823779e-01 | 0.008 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.823779e-01 | 0.008 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.826765e-01 | 0.008 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.827819e-01 | 0.008 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.837650e-01 | 0.007 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.837650e-01 | 0.007 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.837650e-01 | 0.007 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.837650e-01 | 0.007 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.837650e-01 | 0.007 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.842602e-01 | 0.007 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.854053e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.858123e-01 | 0.006 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.859173e-01 | 0.006 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.859173e-01 | 0.006 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.859173e-01 | 0.006 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.859173e-01 | 0.006 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.859173e-01 | 0.006 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.860460e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.860460e-01 | 0.006 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.860460e-01 | 0.006 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.860460e-01 | 0.006 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.865641e-01 | 0.006 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.868323e-01 | 0.006 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.873060e-01 | 0.006 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.873060e-01 | 0.006 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.877843e-01 | 0.005 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.877843e-01 | 0.005 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.877843e-01 | 0.005 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.877843e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.877843e-01 | 0.005 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.877843e-01 | 0.005 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.877843e-01 | 0.005 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.881259e-01 | 0.005 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.890908e-01 | 0.005 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.890908e-01 | 0.005 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.890908e-01 | 0.005 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.894040e-01 | 0.005 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.894040e-01 | 0.005 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.894040e-01 | 0.005 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.894040e-01 | 0.005 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.895952e-01 | 0.005 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.898197e-01 | 0.004 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.898526e-01 | 0.004 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.898526e-01 | 0.004 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.902633e-01 | 0.004 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.903595e-01 | 0.004 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.903595e-01 | 0.004 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.903771e-01 | 0.004 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.908089e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.908089e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.908089e-01 | 0.004 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.908089e-01 | 0.004 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.909336e-01 | 0.004 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.912817e-01 | 0.004 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.912817e-01 | 0.004 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.913185e-01 | 0.004 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.914837e-01 | 0.004 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.914837e-01 | 0.004 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.914837e-01 | 0.004 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.919030e-01 | 0.004 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.920277e-01 | 0.003 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.920277e-01 | 0.003 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.924793e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.924793e-01 | 0.003 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.924793e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.924793e-01 | 0.003 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.924793e-01 | 0.003 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.924793e-01 | 0.003 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.930250e-01 | 0.003 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.930849e-01 | 0.003 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.933607e-01 | 0.003 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.935501e-01 | 0.003 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.940020e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.941406e-01 | 0.003 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.941406e-01 | 0.003 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.942377e-01 | 0.003 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.942469e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.947660e-01 | 0.002 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.947974e-01 | 0.002 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.947974e-01 | 0.002 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.947974e-01 | 0.002 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.948306e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.948306e-01 | 0.002 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.948705e-01 | 0.002 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.952240e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.954159e-01 | 0.002 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.954406e-01 | 0.002 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.954406e-01 | 0.002 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.954406e-01 | 0.002 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.954875e-01 | 0.002 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.954875e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.958848e-01 | 0.002 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.958848e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.958848e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.959268e-01 | 0.002 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.959767e-01 | 0.002 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.959798e-01 | 0.002 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.959798e-01 | 0.002 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.960860e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.963072e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.963310e-01 | 0.002 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.963724e-01 | 0.002 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.964119e-01 | 0.002 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.967703e-01 | 0.001 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.970555e-01 | 0.001 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.970555e-01 | 0.001 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.970555e-01 | 0.001 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.970555e-01 | 0.001 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.971256e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.972383e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.972485e-01 | 0.001 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.973326e-01 | 0.001 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.974462e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.974462e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.977850e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.980414e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.980869e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.980869e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.982300e-01 | 0.001 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.982877e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.983338e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.983338e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.983857e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.984029e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.984029e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.984145e-01 | 0.001 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.985205e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.985549e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.986096e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.986295e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.987197e-01 | 0.001 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.987466e-01 | 0.001 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.987466e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.989046e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.989431e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.990096e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.990096e-01 | 0.000 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.991824e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.991882e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.992187e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.992909e-01 | 0.000 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.992909e-01 | 0.000 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.992909e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.993071e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.993850e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.993850e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.995437e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.995725e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.995811e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.995989e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.995993e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.996214e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.996721e-01 | 0.000 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.996911e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.996983e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.997177e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997288e-01 | 0.000 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.997288e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.997357e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.997384e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.997384e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.997620e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.997789e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.997937e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.998279e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.998392e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.998392e-01 | 0.000 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.998471e-01 | 0.000 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.998471e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.998471e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998477e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998590e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.998887e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.998898e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.998915e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999359e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.999371e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.999371e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.999454e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999501e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999527e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999548e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999590e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999680e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999710e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999837e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999842e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.999857e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.999857e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999869e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999872e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999877e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999886e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999901e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999916e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.999926e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999938e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999949e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999955e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999958e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999958e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999961e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999962e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999969e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999970e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999985e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999987e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999988e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999991e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999991e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999992e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999994e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999994e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999994e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999995e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999999e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999999e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 5.995204e-15 | 14.222 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.995204e-14 | 13.222 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.236300e-13 | 12.490 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.241985e-13 | 12.140 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.841705e-12 | 11.415 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.951550e-11 | 10.710 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.724940e-09 | 8.763 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.258069e-09 | 8.646 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.020277e-09 | 8.299 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.143673e-08 | 7.942 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.053523e-08 | 7.688 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.317754e-08 | 7.635 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.149640e-08 | 7.211 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.877052e-08 | 7.005 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.120387e-07 | 6.951 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.873876e-07 | 6.412 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.513233e-07 | 6.070 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.747327e-07 | 6.058 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.155529e-06 | 5.937 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.528295e-06 | 5.816 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.865748e-06 | 5.729 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.053391e-06 | 5.688 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.527391e-06 | 5.597 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.461470e-06 | 5.263 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.357049e-06 | 5.197 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.131385e-06 | 5.147 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.617188e-06 | 5.065 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.144763e-05 | 4.941 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.287201e-05 | 4.890 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.643335e-05 | 4.784 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.715121e-05 | 4.766 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.768341e-05 | 4.752 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.746307e-05 | 4.758 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.042616e-05 | 4.690 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.409690e-05 | 4.618 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.409690e-05 | 4.618 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.409690e-05 | 4.618 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.409690e-05 | 4.618 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.692419e-05 | 4.570 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.018301e-05 | 4.520 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.052651e-05 | 4.515 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.052651e-05 | 4.515 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.114144e-05 | 4.507 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.398626e-05 | 4.469 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.623730e-05 | 4.441 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.979209e-05 | 4.400 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.261015e-05 | 4.370 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.565404e-05 | 4.341 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.890353e-05 | 4.311 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.890353e-05 | 4.311 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.934432e-05 | 4.159 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.407881e-05 | 4.130 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 7.884806e-05 | 4.103 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.120260e-05 | 4.090 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.663306e-05 | 4.062 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.017351e-04 | 3.993 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.090268e-04 | 3.962 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.209501e-04 | 3.917 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.175952e-04 | 3.930 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.209501e-04 | 3.917 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.246564e-04 | 3.904 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.353878e-04 | 3.868 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.517239e-04 | 3.819 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.543640e-04 | 3.811 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.603434e-04 | 3.795 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.686750e-04 | 3.773 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.711901e-04 | 3.767 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.819129e-04 | 3.740 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.806511e-04 | 3.743 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.783420e-04 | 3.749 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.821054e-04 | 3.740 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.852796e-04 | 3.732 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.988941e-04 | 3.701 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.123772e-04 | 3.673 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.123772e-04 | 3.673 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.174097e-04 | 3.663 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.199520e-04 | 3.658 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.217419e-04 | 3.654 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.618219e-04 | 3.582 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.805281e-04 | 3.552 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.841778e-04 | 3.546 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.857016e-04 | 3.544 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.062327e-04 | 3.514 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.062327e-04 | 3.514 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.208388e-04 | 3.494 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.209544e-04 | 3.494 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.498373e-04 | 3.456 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.498373e-04 | 3.456 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.409018e-04 | 3.467 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.637824e-04 | 3.439 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.089617e-04 | 3.388 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.375262e-04 | 3.359 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.577351e-04 | 3.339 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.577351e-04 | 3.339 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.403989e-04 | 3.356 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.665427e-04 | 3.331 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.675912e-04 | 3.330 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.212116e-04 | 3.283 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.264109e-04 | 3.279 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.703320e-04 | 3.244 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.703320e-04 | 3.244 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.768124e-04 | 3.239 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.048990e-04 | 3.218 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.323216e-04 | 3.199 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.782516e-04 | 3.169 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.727351e-04 | 3.172 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.585777e-04 | 3.181 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.782516e-04 | 3.169 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 6.782516e-04 | 3.169 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.405297e-04 | 3.193 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.287002e-04 | 3.137 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.581400e-04 | 3.120 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.927257e-04 | 3.101 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.165105e-04 | 3.088 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.531860e-04 | 3.069 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.601659e-04 | 3.065 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 9.854908e-04 | 3.006 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 9.854908e-04 | 3.006 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.443163e-04 | 3.025 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 9.287461e-04 | 3.032 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.100433e-03 | 2.958 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.142501e-03 | 2.942 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.173344e-03 | 2.931 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.229345e-03 | 2.910 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.241580e-03 | 2.906 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.253330e-03 | 2.902 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.487713e-03 | 2.827 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.492502e-03 | 2.826 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.531677e-03 | 2.815 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.742108e-03 | 2.759 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.761322e-03 | 2.754 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.785892e-03 | 2.748 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.795233e-03 | 2.746 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.808031e-03 | 2.743 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.808031e-03 | 2.743 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.822129e-03 | 2.739 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.870394e-03 | 2.728 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.950185e-03 | 2.710 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.201852e-03 | 2.657 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.108344e-03 | 2.676 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.297911e-03 | 2.639 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.330887e-03 | 2.632 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.617374e-03 | 2.582 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.771416e-03 | 2.557 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.858129e-03 | 2.544 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.272816e-03 | 2.485 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.893679e-03 | 2.410 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.046503e-03 | 2.393 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.116212e-03 | 2.386 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.907769e-03 | 2.408 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.812375e-03 | 2.419 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.812375e-03 | 2.419 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.174303e-03 | 2.379 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.792907e-03 | 2.421 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.264302e-03 | 2.370 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.264302e-03 | 2.370 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.264302e-03 | 2.370 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.270777e-03 | 2.369 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.371304e-03 | 2.359 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.607909e-03 | 2.336 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.629593e-03 | 2.334 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.710904e-03 | 2.327 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.950389e-03 | 2.305 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.124084e-03 | 2.290 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.180433e-03 | 2.286 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.394784e-03 | 2.268 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.469193e-03 | 2.262 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.104954e-03 | 2.214 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.289398e-03 | 2.201 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.405632e-03 | 2.193 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.131490e-03 | 2.212 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.104954e-03 | 2.214 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.289398e-03 | 2.201 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.475128e-03 | 2.189 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.618730e-03 | 2.179 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.767226e-03 | 2.170 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.767226e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.767226e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.767226e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.767226e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.767226e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.767226e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.767226e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.767226e-03 | 2.170 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.767226e-03 | 2.170 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.767226e-03 | 2.170 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.908163e-03 | 2.161 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.922974e-03 | 2.160 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.922974e-03 | 2.160 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.039730e-03 | 2.152 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.423317e-03 | 2.129 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.878038e-03 | 2.104 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.974837e-03 | 2.098 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.060542e-03 | 2.094 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.442571e-03 | 2.074 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 8.442571e-03 | 2.074 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.016001e-02 | 1.993 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.362539e-03 | 2.029 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 1.013350e-02 | 1.994 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.016001e-02 | 1.993 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.050211e-02 | 1.979 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.051374e-02 | 1.978 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.066561e-02 | 1.972 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.220753e-02 | 1.913 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.233454e-02 | 1.909 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.266482e-02 | 1.897 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.319433e-02 | 1.880 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.335214e-02 | 1.874 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.424063e-02 | 1.846 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.442816e-02 | 1.841 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.458970e-02 | 1.836 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.484069e-02 | 1.829 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.498662e-02 | 1.824 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.552211e-02 | 1.809 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.601173e-02 | 1.796 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.676844e-02 | 1.776 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.733567e-02 | 1.761 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.760478e-02 | 1.754 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.780545e-02 | 1.749 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.780545e-02 | 1.749 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.138373e-02 | 1.670 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.138373e-02 | 1.670 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.946964e-02 | 1.711 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.870523e-02 | 1.728 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.970289e-02 | 1.705 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.970289e-02 | 1.705 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.854902e-02 | 1.732 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.989772e-02 | 1.701 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.031834e-02 | 1.692 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.090080e-02 | 1.680 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.090080e-02 | 1.680 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.848048e-02 | 1.733 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.237329e-02 | 1.650 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.275301e-02 | 1.643 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.346357e-02 | 1.630 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.387043e-02 | 1.622 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.523569e-02 | 1.598 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.560274e-02 | 1.592 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.590173e-02 | 1.587 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.629734e-02 | 1.580 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.630718e-02 | 1.580 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.641568e-02 | 1.578 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.817118e-02 | 1.550 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.947355e-02 | 1.531 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.949801e-02 | 1.530 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.949801e-02 | 1.530 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.950783e-02 | 1.530 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.950783e-02 | 1.530 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.087872e-02 | 1.510 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.178623e-02 | 1.498 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.284092e-02 | 1.484 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.316925e-02 | 1.479 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.325763e-02 | 1.478 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.325763e-02 | 1.478 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.530170e-02 | 1.452 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.584191e-02 | 1.446 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.610297e-02 | 1.442 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.610297e-02 | 1.442 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.610297e-02 | 1.442 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.616989e-02 | 1.442 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.114962e-02 | 1.386 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.114962e-02 | 1.386 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.947350e-02 | 1.404 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.868626e-02 | 1.412 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.000993e-02 | 1.398 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.007133e-02 | 1.397 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.947350e-02 | 1.404 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.480512e-02 | 1.349 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.947350e-02 | 1.404 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.745179e-02 | 1.427 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.209367e-02 | 1.376 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.994365e-02 | 1.399 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.016387e-02 | 1.396 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.520216e-02 | 1.345 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.520216e-02 | 1.345 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.520216e-02 | 1.345 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.608282e-02 | 1.336 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.693198e-02 | 1.329 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.749942e-02 | 1.323 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.779703e-02 | 1.321 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.812106e-02 | 1.318 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.094815e-02 | 1.293 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.094815e-02 | 1.293 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.164530e-02 | 1.287 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.210431e-02 | 1.283 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.447202e-02 | 1.264 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.475673e-02 | 1.262 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.520471e-02 | 1.258 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 5.544822e-02 | 1.256 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.568707e-02 | 1.254 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.568707e-02 | 1.254 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.602205e-02 | 1.252 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.615669e-02 | 1.251 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.692824e-02 | 1.245 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.891349e-02 | 1.230 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.892317e-02 | 1.230 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.970407e-02 | 1.224 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.081421e-02 | 1.216 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.114525e-02 | 1.214 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.196983e-02 | 1.208 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.197722e-02 | 1.208 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.234791e-02 | 1.205 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.268202e-02 | 1.203 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.268999e-02 | 1.203 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.022436e-02 | 1.154 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.684512e-02 | 1.175 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.935644e-02 | 1.100 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.961228e-02 | 1.099 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.773498e-02 | 1.169 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.646618e-02 | 1.117 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.789498e-02 | 1.168 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.910172e-02 | 1.161 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 6.684512e-02 | 1.175 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.926171e-02 | 1.160 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.912963e-02 | 1.102 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.684512e-02 | 1.175 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.646618e-02 | 1.117 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.407200e-02 | 1.193 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.773498e-02 | 1.169 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.684512e-02 | 1.175 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.684512e-02 | 1.175 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.684512e-02 | 1.175 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.773498e-02 | 1.169 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.773498e-02 | 1.169 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.097429e-02 | 1.149 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.154299e-02 | 1.145 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.516219e-02 | 1.124 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.789498e-02 | 1.168 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.702204e-02 | 1.174 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.715014e-02 | 1.173 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.769454e-02 | 1.110 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.935644e-02 | 1.100 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.102955e-02 | 1.149 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.419870e-02 | 1.192 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.992657e-02 | 1.097 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.144971e-02 | 1.089 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 8.179942e-02 | 1.087 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 8.179942e-02 | 1.087 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.447465e-02 | 1.073 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 8.700091e-02 | 1.060 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 8.741976e-02 | 1.058 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 8.741976e-02 | 1.058 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.800695e-02 | 1.055 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.837937e-02 | 1.054 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 8.883888e-02 | 1.051 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.007698e-02 | 1.045 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.007698e-02 | 1.045 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.041159e-02 | 1.044 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 9.074059e-02 | 1.042 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 9.074059e-02 | 1.042 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 9.074059e-02 | 1.042 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 9.074059e-02 | 1.042 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.074059e-02 | 1.042 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 9.074059e-02 | 1.042 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.190812e-02 | 1.037 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 9.354431e-02 | 1.029 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.418327e-02 | 1.026 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.421737e-02 | 1.026 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 9.476356e-02 | 1.023 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.731731e-02 | 1.012 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.018443e-01 | 0.992 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.042024e-01 | 0.982 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.054435e-01 | 0.977 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.054435e-01 | 0.977 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.109254e-01 | 0.955 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.109254e-01 | 0.955 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.061909e-01 | 0.974 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.061909e-01 | 0.974 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.263734e-01 | 0.898 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.075451e-01 | 0.968 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.075451e-01 | 0.968 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.231098e-01 | 0.910 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.395672e-01 | 0.855 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.152406e-01 | 0.938 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.173500e-01 | 0.931 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.173500e-01 | 0.931 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.289943e-01 | 0.889 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.166195e-01 | 0.933 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.232797e-01 | 0.909 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.395672e-01 | 0.855 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.080792e-01 | 0.966 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 1.285545e-01 | 0.891 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.076059e-01 | 0.968 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.231098e-01 | 0.910 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.348374e-01 | 0.870 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.200289e-01 | 0.921 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.335681e-01 | 0.874 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.062994e-01 | 0.973 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.395672e-01 | 0.855 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.196376e-01 | 0.922 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.208927e-01 | 0.918 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.218681e-01 | 0.914 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.411704e-01 | 0.850 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.218681e-01 | 0.914 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.083456e-01 | 0.965 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.263734e-01 | 0.898 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.067337e-01 | 0.972 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.372414e-01 | 0.863 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.129490e-01 | 0.947 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.285545e-01 | 0.891 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.411704e-01 | 0.850 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.269637e-01 | 0.896 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.315611e-01 | 0.881 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.119122e-01 | 0.951 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.321156e-01 | 0.879 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.321156e-01 | 0.879 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.061909e-01 | 0.974 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.264535e-01 | 0.898 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.075451e-01 | 0.968 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.395672e-01 | 0.855 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.285545e-01 | 0.891 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.269637e-01 | 0.896 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.100301e-01 | 0.958 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.097493e-01 | 0.960 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.109254e-01 | 0.955 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.143465e-01 | 0.942 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.075451e-01 | 0.968 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 1.263734e-01 | 0.898 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.334866e-01 | 0.875 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.272545e-01 | 0.895 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.061909e-01 | 0.974 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.422563e-01 | 0.847 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.422563e-01 | 0.847 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.425318e-01 | 0.846 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.429015e-01 | 0.845 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.433708e-01 | 0.844 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.477966e-01 | 0.830 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.477966e-01 | 0.830 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.477966e-01 | 0.830 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.477966e-01 | 0.830 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.477966e-01 | 0.830 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.482910e-01 | 0.829 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.489731e-01 | 0.827 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.720450e-01 | 0.764 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.720450e-01 | 0.764 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.720450e-01 | 0.764 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.720450e-01 | 0.764 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.720450e-01 | 0.764 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 1.720450e-01 | 0.764 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.720450e-01 | 0.764 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.720450e-01 | 0.764 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 1.720450e-01 | 0.764 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.720450e-01 | 0.764 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.720450e-01 | 0.764 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.720450e-01 | 0.764 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.720450e-01 | 0.764 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.720450e-01 | 0.764 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.466335e-01 | 0.608 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 2.466335e-01 | 0.608 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.466335e-01 | 0.608 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.466335e-01 | 0.608 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.466335e-01 | 0.608 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.466335e-01 | 0.608 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.466335e-01 | 0.608 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.466335e-01 | 0.608 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.466335e-01 | 0.608 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 1.751590e-01 | 0.757 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.145065e-01 | 0.502 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.145065e-01 | 0.502 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.145065e-01 | 0.502 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.145065e-01 | 0.502 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.702878e-01 | 0.769 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.702878e-01 | 0.769 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.436164e-01 | 0.613 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 2.436164e-01 | 0.613 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.436164e-01 | 0.613 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.436164e-01 | 0.613 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 3.762683e-01 | 0.425 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.762683e-01 | 0.425 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.762683e-01 | 0.425 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.762683e-01 | 0.425 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.936761e-01 | 0.713 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.936761e-01 | 0.713 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.936761e-01 | 0.713 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.936761e-01 | 0.713 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.936761e-01 | 0.713 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.936761e-01 | 0.713 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.936761e-01 | 0.713 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.936761e-01 | 0.713 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.568444e-01 | 0.805 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.177950e-01 | 0.662 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.748649e-01 | 0.757 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.571332e-01 | 0.804 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.129456e-01 | 0.505 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.129456e-01 | 0.505 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.129456e-01 | 0.505 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 3.129456e-01 | 0.505 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 3.129456e-01 | 0.505 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.129456e-01 | 0.505 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.324688e-01 | 0.364 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.324688e-01 | 0.364 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.324688e-01 | 0.364 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.324688e-01 | 0.364 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.324688e-01 | 0.364 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.324688e-01 | 0.364 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.324688e-01 | 0.364 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.324688e-01 | 0.364 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.723167e-01 | 0.764 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.723167e-01 | 0.764 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.723167e-01 | 0.764 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.128168e-01 | 0.672 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.128168e-01 | 0.672 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.538549e-01 | 0.813 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.675941e-01 | 0.573 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.670220e-01 | 0.777 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.325866e-01 | 0.633 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.471778e-01 | 0.459 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.471778e-01 | 0.459 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.042491e-01 | 0.690 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.929809e-01 | 0.533 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 2.929809e-01 | 0.533 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.929809e-01 | 0.533 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.379518e-01 | 0.624 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.379518e-01 | 0.624 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.733125e-01 | 0.563 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.185132e-01 | 0.497 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.808217e-01 | 0.419 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.553446e-01 | 0.593 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.553446e-01 | 0.593 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.390713e-01 | 0.621 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.440697e-01 | 0.463 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.137055e-01 | 0.383 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.379845e-01 | 0.623 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.379845e-01 | 0.623 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.695396e-01 | 0.432 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.695396e-01 | 0.432 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.948228e-01 | 0.404 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.948228e-01 | 0.404 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.456931e-01 | 0.351 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.456931e-01 | 0.351 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.457680e-01 | 0.461 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.785289e-01 | 0.422 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.348976e-01 | 0.475 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.198298e-01 | 0.377 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 4.198298e-01 | 0.377 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.397283e-01 | 0.469 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.444811e-01 | 0.352 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.548065e-01 | 0.450 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.205591e-01 | 0.376 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.205591e-01 | 0.376 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.413303e-01 | 0.355 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.559131e-01 | 0.341 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.306459e-01 | 0.366 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 3.184982e-01 | 0.497 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.983805e-01 | 0.525 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.368830e-01 | 0.473 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.457680e-01 | 0.461 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.444811e-01 | 0.352 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.726358e-01 | 0.763 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.573777e-01 | 0.447 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.702878e-01 | 0.769 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.221233e-01 | 0.653 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.553446e-01 | 0.593 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.137055e-01 | 0.383 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.875894e-01 | 0.727 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.083475e-01 | 0.681 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 4.011177e-01 | 0.397 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.810375e-01 | 0.551 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.826781e-01 | 0.417 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.545010e-01 | 0.594 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.362146e-01 | 0.473 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.436164e-01 | 0.613 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.471778e-01 | 0.459 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.606067e-01 | 0.794 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.808217e-01 | 0.419 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 3.808217e-01 | 0.419 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.440697e-01 | 0.463 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.909668e-01 | 0.536 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.022252e-01 | 0.520 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.994654e-01 | 0.700 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.553446e-01 | 0.593 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.091655e-01 | 0.510 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 2.929809e-01 | 0.533 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.457680e-01 | 0.461 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.670220e-01 | 0.777 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.783381e-01 | 0.555 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 2.783381e-01 | 0.555 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 2.177950e-01 | 0.662 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.185132e-01 | 0.497 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.239375e-01 | 0.650 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.948228e-01 | 0.404 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.456931e-01 | 0.351 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.579368e-01 | 0.446 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.348976e-01 | 0.475 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.295081e-01 | 0.367 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.983805e-01 | 0.525 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.042491e-01 | 0.690 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.456931e-01 | 0.351 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.642146e-01 | 0.439 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.826781e-01 | 0.417 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.131465e-01 | 0.384 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.513205e-01 | 0.600 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.471778e-01 | 0.459 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.987999e-01 | 0.702 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.194942e-01 | 0.377 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.826781e-01 | 0.417 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.273812e-01 | 0.485 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.720450e-01 | 0.764 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.436164e-01 | 0.613 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 2.783381e-01 | 0.555 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.129456e-01 | 0.505 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.137055e-01 | 0.383 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.362146e-01 | 0.473 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.090988e-01 | 0.510 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.152106e-01 | 0.501 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.152106e-01 | 0.501 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.152106e-01 | 0.501 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.152106e-01 | 0.501 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.505886e-01 | 0.346 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.519349e-01 | 0.599 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.716778e-01 | 0.566 | 0 | 0 |
| Translation | R-HSA-72766 | 2.607396e-01 | 0.584 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.695396e-01 | 0.432 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.272282e-01 | 0.369 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.091332e-01 | 0.680 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.406872e-01 | 0.619 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.695396e-01 | 0.432 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.456931e-01 | 0.351 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.566278e-01 | 0.805 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 1.571332e-01 | 0.804 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.177950e-01 | 0.662 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 4.456931e-01 | 0.351 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.573777e-01 | 0.447 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.751590e-01 | 0.757 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.424848e-01 | 0.615 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.324688e-01 | 0.364 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.880375e-01 | 0.726 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.537848e-01 | 0.813 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.733125e-01 | 0.563 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 3.808217e-01 | 0.419 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.695396e-01 | 0.432 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.298209e-01 | 0.639 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.818405e-01 | 0.418 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.604264e-01 | 0.795 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.545010e-01 | 0.594 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.356927e-01 | 0.474 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.573777e-01 | 0.447 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.325884e-01 | 0.633 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.128168e-01 | 0.672 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.880375e-01 | 0.726 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.948228e-01 | 0.404 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.805215e-01 | 0.552 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 3.573777e-01 | 0.447 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.462333e-01 | 0.461 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.174550e-01 | 0.498 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.703834e-01 | 0.431 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.209807e-01 | 0.656 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.720450e-01 | 0.764 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.720450e-01 | 0.764 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.720450e-01 | 0.764 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.466335e-01 | 0.608 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.466335e-01 | 0.608 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.466335e-01 | 0.608 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.466335e-01 | 0.608 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.145065e-01 | 0.502 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.145065e-01 | 0.502 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.090968e-01 | 0.680 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.702878e-01 | 0.769 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.702878e-01 | 0.769 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 3.762683e-01 | 0.425 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.762683e-01 | 0.425 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.762683e-01 | 0.425 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.177950e-01 | 0.662 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 2.424848e-01 | 0.615 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.129456e-01 | 0.505 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.129456e-01 | 0.505 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 3.471778e-01 | 0.459 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.379518e-01 | 0.624 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.808217e-01 | 0.419 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.137055e-01 | 0.383 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.695396e-01 | 0.432 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.785289e-01 | 0.422 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.996080e-01 | 0.398 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.559131e-01 | 0.341 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.559131e-01 | 0.341 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.068101e-01 | 0.513 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.870987e-01 | 0.728 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.033808e-01 | 0.394 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.406957e-01 | 0.468 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.880375e-01 | 0.726 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.695396e-01 | 0.432 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.708890e-01 | 0.431 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.021869e-01 | 0.694 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.723167e-01 | 0.764 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.444811e-01 | 0.352 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.090988e-01 | 0.510 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.883979e-01 | 0.411 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 3.129456e-01 | 0.505 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.746837e-01 | 0.426 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.290855e-01 | 0.640 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.290013e-01 | 0.483 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.091332e-01 | 0.680 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.805215e-01 | 0.552 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.129456e-01 | 0.505 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.444811e-01 | 0.352 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.098335e-01 | 0.387 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.749083e-01 | 0.561 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.011177e-01 | 0.397 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.614342e-01 | 0.583 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.152106e-01 | 0.501 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.413303e-01 | 0.355 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.806440e-01 | 0.743 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.090968e-01 | 0.680 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.424848e-01 | 0.615 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.129456e-01 | 0.505 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.324688e-01 | 0.364 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.456931e-01 | 0.351 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.552805e-01 | 0.342 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.813932e-01 | 0.551 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.472864e-01 | 0.459 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.723167e-01 | 0.764 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.042491e-01 | 0.690 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.861121e-01 | 0.543 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.861121e-01 | 0.543 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.764382e-01 | 0.753 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.502740e-01 | 0.347 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.082667e-01 | 0.389 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.404787e-01 | 0.356 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.466335e-01 | 0.608 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.751590e-01 | 0.757 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.702878e-01 | 0.769 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.762683e-01 | 0.425 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.568444e-01 | 0.805 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.129456e-01 | 0.505 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.129456e-01 | 0.505 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.129456e-01 | 0.505 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.675941e-01 | 0.573 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.670220e-01 | 0.777 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.929809e-01 | 0.533 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.614342e-01 | 0.583 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 4.198298e-01 | 0.377 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.444811e-01 | 0.352 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.205591e-01 | 0.376 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.239268e-01 | 0.373 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.559131e-01 | 0.341 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.626578e-01 | 0.789 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.362129e-01 | 0.473 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.205591e-01 | 0.376 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.362129e-01 | 0.473 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.362129e-01 | 0.473 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.290855e-01 | 0.640 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.022252e-01 | 0.520 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.198298e-01 | 0.377 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.579368e-01 | 0.446 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.768307e-01 | 0.752 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.519349e-01 | 0.599 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.022252e-01 | 0.520 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.347625e-01 | 0.629 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.319525e-01 | 0.479 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.645488e-01 | 0.784 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.661224e-01 | 0.575 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.094830e-01 | 0.509 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.762683e-01 | 0.425 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.424848e-01 | 0.615 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.471778e-01 | 0.459 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.935492e-01 | 0.713 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.675070e-01 | 0.776 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.009746e-01 | 0.397 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.444811e-01 | 0.352 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.011156e-01 | 0.397 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 1.751590e-01 | 0.757 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.702878e-01 | 0.769 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.436164e-01 | 0.613 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.129456e-01 | 0.505 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.471778e-01 | 0.459 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.527782e-01 | 0.597 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 1.645488e-01 | 0.784 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.108932e-01 | 0.676 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.137055e-01 | 0.383 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.198298e-01 | 0.377 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.613542e-01 | 0.583 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.954555e-01 | 0.709 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.334653e-01 | 0.363 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.397283e-01 | 0.469 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 2.424848e-01 | 0.615 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.456931e-01 | 0.351 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 3.843135e-01 | 0.415 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.339840e-01 | 0.476 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.941124e-01 | 0.531 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.746307e-01 | 0.561 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.430614e-01 | 0.354 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.436164e-01 | 0.613 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.436164e-01 | 0.613 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.783381e-01 | 0.555 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.129456e-01 | 0.505 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.808217e-01 | 0.419 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.996080e-01 | 0.398 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.198682e-01 | 0.377 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.826781e-01 | 0.417 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.185132e-01 | 0.497 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.941124e-01 | 0.531 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.614342e-01 | 0.583 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.377709e-01 | 0.359 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.129456e-01 | 0.505 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.129456e-01 | 0.505 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.566278e-01 | 0.805 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.059750e-01 | 0.686 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 2.424848e-01 | 0.615 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.580161e-01 | 0.446 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.362146e-01 | 0.473 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.444811e-01 | 0.352 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.471778e-01 | 0.459 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.996080e-01 | 0.398 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 3.785289e-01 | 0.422 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 1.748649e-01 | 0.757 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 2.733125e-01 | 0.563 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.575130e-01 | 0.340 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.575844e-01 | 0.340 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.607720e-01 | 0.337 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 4.607720e-01 | 0.337 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.687068e-01 | 0.329 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.687068e-01 | 0.329 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 4.687068e-01 | 0.329 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.738884e-01 | 0.324 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.766793e-01 | 0.322 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.766793e-01 | 0.322 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.766793e-01 | 0.322 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.766793e-01 | 0.322 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.766793e-01 | 0.322 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.766793e-01 | 0.322 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.821471e-01 | 0.317 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.821471e-01 | 0.317 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.821471e-01 | 0.317 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.821471e-01 | 0.317 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.836085e-01 | 0.316 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.836085e-01 | 0.316 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.836085e-01 | 0.316 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.836085e-01 | 0.316 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 4.836085e-01 | 0.316 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.836085e-01 | 0.316 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.836085e-01 | 0.316 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 4.836085e-01 | 0.316 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 4.836085e-01 | 0.316 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.836085e-01 | 0.316 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.883396e-01 | 0.311 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 4.894241e-01 | 0.310 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.905324e-01 | 0.309 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.924465e-01 | 0.308 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.924465e-01 | 0.308 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.924465e-01 | 0.308 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.968391e-01 | 0.304 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.990936e-01 | 0.302 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.021102e-01 | 0.299 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.021102e-01 | 0.299 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.021102e-01 | 0.299 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.021102e-01 | 0.299 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.023236e-01 | 0.299 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.052298e-01 | 0.297 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.065847e-01 | 0.295 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.065847e-01 | 0.295 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.065847e-01 | 0.295 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.065847e-01 | 0.295 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.065847e-01 | 0.295 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.149388e-01 | 0.288 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.156482e-01 | 0.288 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.197830e-01 | 0.284 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 5.217281e-01 | 0.283 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.217281e-01 | 0.283 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.230770e-01 | 0.281 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.240250e-01 | 0.281 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.277986e-01 | 0.278 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.278257e-01 | 0.278 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.301428e-01 | 0.276 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.301428e-01 | 0.276 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.301428e-01 | 0.276 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.301428e-01 | 0.276 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.301428e-01 | 0.276 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.301428e-01 | 0.276 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.301428e-01 | 0.276 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.301428e-01 | 0.276 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.301428e-01 | 0.276 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.301428e-01 | 0.276 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.301428e-01 | 0.276 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.301428e-01 | 0.276 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.301428e-01 | 0.276 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.344823e-01 | 0.272 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.353526e-01 | 0.271 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.353526e-01 | 0.271 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.353526e-01 | 0.271 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.353526e-01 | 0.271 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.353526e-01 | 0.271 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.353526e-01 | 0.271 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.353526e-01 | 0.271 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.353526e-01 | 0.271 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.353526e-01 | 0.271 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.353526e-01 | 0.271 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.353526e-01 | 0.271 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.374215e-01 | 0.270 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.382682e-01 | 0.269 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 5.409698e-01 | 0.267 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.409698e-01 | 0.267 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.409698e-01 | 0.267 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.435522e-01 | 0.265 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.460252e-01 | 0.263 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.477889e-01 | 0.261 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.508568e-01 | 0.259 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.549690e-01 | 0.256 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 5.570067e-01 | 0.254 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.598078e-01 | 0.252 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.602703e-01 | 0.252 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 5.602703e-01 | 0.252 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.602869e-01 | 0.252 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.602869e-01 | 0.252 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.608907e-01 | 0.251 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.612315e-01 | 0.251 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.629451e-01 | 0.250 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.629451e-01 | 0.250 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.629451e-01 | 0.250 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.629451e-01 | 0.250 | 0 | 0 |
| Mineralocorticoid biosynthesis | R-HSA-193993 | 5.629451e-01 | 0.250 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.681109e-01 | 0.246 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.724862e-01 | 0.242 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.724862e-01 | 0.242 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.724862e-01 | 0.242 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.724862e-01 | 0.242 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.724862e-01 | 0.242 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.724862e-01 | 0.242 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.724862e-01 | 0.242 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.724862e-01 | 0.242 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.724862e-01 | 0.242 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 5.724862e-01 | 0.242 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.724862e-01 | 0.242 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.724862e-01 | 0.242 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.724862e-01 | 0.242 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.782183e-01 | 0.238 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.782183e-01 | 0.238 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.782183e-01 | 0.238 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.816252e-01 | 0.235 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.816252e-01 | 0.235 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.833187e-01 | 0.234 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.892650e-01 | 0.230 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.893405e-01 | 0.230 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.893405e-01 | 0.230 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.893405e-01 | 0.230 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 5.893405e-01 | 0.230 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.893613e-01 | 0.230 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.908944e-01 | 0.228 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.927987e-01 | 0.227 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.961812e-01 | 0.225 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.007105e-01 | 0.221 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.008053e-01 | 0.221 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.008053e-01 | 0.221 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.008243e-01 | 0.221 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.014406e-01 | 0.221 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.023101e-01 | 0.220 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.023101e-01 | 0.220 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.023101e-01 | 0.220 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 6.023101e-01 | 0.220 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 6.053247e-01 | 0.218 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.085446e-01 | 0.216 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.110159e-01 | 0.214 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.110159e-01 | 0.214 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.110159e-01 | 0.214 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.110159e-01 | 0.214 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.110159e-01 | 0.214 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.110159e-01 | 0.214 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.110159e-01 | 0.214 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.110159e-01 | 0.214 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.110159e-01 | 0.214 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.110159e-01 | 0.214 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.110159e-01 | 0.214 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.110159e-01 | 0.214 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.110159e-01 | 0.214 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.110159e-01 | 0.214 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.110159e-01 | 0.214 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.110159e-01 | 0.214 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.116746e-01 | 0.213 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.136793e-01 | 0.212 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.136793e-01 | 0.212 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.145305e-01 | 0.211 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.145305e-01 | 0.211 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.145305e-01 | 0.211 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.145305e-01 | 0.211 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.145305e-01 | 0.211 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.145305e-01 | 0.211 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.145305e-01 | 0.211 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.145305e-01 | 0.211 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.145305e-01 | 0.211 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.145305e-01 | 0.211 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.164348e-01 | 0.210 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.164348e-01 | 0.210 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.295913e-01 | 0.201 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.306225e-01 | 0.200 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.306988e-01 | 0.200 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.309372e-01 | 0.200 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.309372e-01 | 0.200 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.333277e-01 | 0.198 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.333277e-01 | 0.198 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.368875e-01 | 0.196 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.385178e-01 | 0.195 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 6.385178e-01 | 0.195 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.385178e-01 | 0.195 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.385178e-01 | 0.195 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.385178e-01 | 0.195 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.385178e-01 | 0.195 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.460751e-01 | 0.190 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.460751e-01 | 0.190 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.460751e-01 | 0.190 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.460751e-01 | 0.190 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.460751e-01 | 0.190 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.460751e-01 | 0.190 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.460751e-01 | 0.190 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.460751e-01 | 0.190 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.460751e-01 | 0.190 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.460751e-01 | 0.190 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.460751e-01 | 0.190 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.460751e-01 | 0.190 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.460751e-01 | 0.190 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.460751e-01 | 0.190 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.460751e-01 | 0.190 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.460751e-01 | 0.190 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.472288e-01 | 0.189 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.472288e-01 | 0.189 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.547573e-01 | 0.184 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.547573e-01 | 0.184 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.568961e-01 | 0.183 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.576473e-01 | 0.182 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.593499e-01 | 0.181 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.602002e-01 | 0.180 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.602002e-01 | 0.180 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.613147e-01 | 0.180 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.613147e-01 | 0.180 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.613147e-01 | 0.180 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 6.613147e-01 | 0.180 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.613147e-01 | 0.180 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.632609e-01 | 0.178 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.637182e-01 | 0.178 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.678525e-01 | 0.175 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.678525e-01 | 0.175 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.678525e-01 | 0.175 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.700422e-01 | 0.174 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.719005e-01 | 0.173 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.729431e-01 | 0.172 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.746731e-01 | 0.171 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.779764e-01 | 0.169 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.779764e-01 | 0.169 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.779764e-01 | 0.169 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.779764e-01 | 0.169 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.779764e-01 | 0.169 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.779764e-01 | 0.169 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.779764e-01 | 0.169 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.779764e-01 | 0.169 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.780850e-01 | 0.169 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.780850e-01 | 0.169 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.780850e-01 | 0.169 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.787894e-01 | 0.168 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.787894e-01 | 0.168 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.817197e-01 | 0.166 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.817197e-01 | 0.166 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.829408e-01 | 0.166 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.829408e-01 | 0.166 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.829408e-01 | 0.166 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.829408e-01 | 0.166 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.844895e-01 | 0.165 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.846906e-01 | 0.165 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.894348e-01 | 0.162 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.938108e-01 | 0.159 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.938108e-01 | 0.159 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.951925e-01 | 0.158 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.034220e-01 | 0.153 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.034220e-01 | 0.153 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.034220e-01 | 0.153 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.034220e-01 | 0.153 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.034220e-01 | 0.153 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.070039e-01 | 0.151 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.070039e-01 | 0.151 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.070039e-01 | 0.151 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.070039e-01 | 0.151 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.070039e-01 | 0.151 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.070039e-01 | 0.151 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.070039e-01 | 0.151 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.073741e-01 | 0.150 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.082680e-01 | 0.150 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.083238e-01 | 0.150 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.099263e-01 | 0.149 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.117368e-01 | 0.148 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.117368e-01 | 0.148 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.117368e-01 | 0.148 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.117368e-01 | 0.148 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 7.189290e-01 | 0.143 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.209451e-01 | 0.142 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.209451e-01 | 0.142 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.223291e-01 | 0.141 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.227888e-01 | 0.141 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.227888e-01 | 0.141 | 0 | 0 |
| Glucocorticoid biosynthesis | R-HSA-194002 | 7.227888e-01 | 0.141 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.227888e-01 | 0.141 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 7.227888e-01 | 0.141 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.233269e-01 | 0.141 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.275156e-01 | 0.138 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.275156e-01 | 0.138 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.286742e-01 | 0.137 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.304751e-01 | 0.136 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.332234e-01 | 0.135 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.334165e-01 | 0.135 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.334165e-01 | 0.135 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.334165e-01 | 0.135 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.334165e-01 | 0.135 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.334165e-01 | 0.135 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.334165e-01 | 0.135 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 7.334165e-01 | 0.135 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.334165e-01 | 0.135 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.334165e-01 | 0.135 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.334165e-01 | 0.135 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.334165e-01 | 0.135 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.334165e-01 | 0.135 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.358290e-01 | 0.133 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.358290e-01 | 0.133 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.358290e-01 | 0.133 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.373956e-01 | 0.132 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.410758e-01 | 0.130 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.410758e-01 | 0.130 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.410758e-01 | 0.130 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.410758e-01 | 0.130 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 7.410758e-01 | 0.130 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.410758e-01 | 0.130 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.426086e-01 | 0.129 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.426086e-01 | 0.129 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.426086e-01 | 0.129 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.426086e-01 | 0.129 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.438469e-01 | 0.129 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.438469e-01 | 0.129 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.479388e-01 | 0.126 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.488276e-01 | 0.126 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.488276e-01 | 0.126 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.488276e-01 | 0.126 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.488276e-01 | 0.126 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.565894e-01 | 0.121 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.574494e-01 | 0.121 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.574494e-01 | 0.121 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.574494e-01 | 0.121 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.574494e-01 | 0.121 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.574494e-01 | 0.121 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.574494e-01 | 0.121 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.574494e-01 | 0.121 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.574494e-01 | 0.121 | 0 | 0 |
| FMO oxidises nucleophiles | R-HSA-217271 | 7.574494e-01 | 0.121 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.583201e-01 | 0.120 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 7.583201e-01 | 0.120 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.583201e-01 | 0.120 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.583201e-01 | 0.120 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.583201e-01 | 0.120 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.583201e-01 | 0.120 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.613302e-01 | 0.118 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.648189e-01 | 0.116 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.648189e-01 | 0.116 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.657695e-01 | 0.116 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.674611e-01 | 0.115 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.674611e-01 | 0.115 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.674611e-01 | 0.115 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.674611e-01 | 0.115 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.715961e-01 | 0.113 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.745611e-01 | 0.111 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.745611e-01 | 0.111 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.745611e-01 | 0.111 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.745611e-01 | 0.111 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.745611e-01 | 0.111 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.793171e-01 | 0.108 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.793171e-01 | 0.108 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.793171e-01 | 0.108 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.793171e-01 | 0.108 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.793171e-01 | 0.108 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.793171e-01 | 0.108 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.793171e-01 | 0.108 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.793171e-01 | 0.108 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.793171e-01 | 0.108 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.793171e-01 | 0.108 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 7.793171e-01 | 0.108 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.793171e-01 | 0.108 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.806392e-01 | 0.108 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 7.839037e-01 | 0.106 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.839037e-01 | 0.106 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.848758e-01 | 0.105 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.887069e-01 | 0.103 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.891564e-01 | 0.103 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.898395e-01 | 0.102 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.898395e-01 | 0.102 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.898395e-01 | 0.102 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.898395e-01 | 0.102 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.898395e-01 | 0.102 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.898395e-01 | 0.102 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.959353e-01 | 0.099 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.965762e-01 | 0.099 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 7.976921e-01 | 0.098 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.986491e-01 | 0.098 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.986491e-01 | 0.098 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.992144e-01 | 0.097 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.992144e-01 | 0.097 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 7.992144e-01 | 0.097 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.992144e-01 | 0.097 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 7.992144e-01 | 0.097 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.992144e-01 | 0.097 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 7.992144e-01 | 0.097 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.992144e-01 | 0.097 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.995951e-01 | 0.097 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.041969e-01 | 0.095 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.041969e-01 | 0.095 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.065319e-01 | 0.093 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.074189e-01 | 0.093 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.082715e-01 | 0.092 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.082715e-01 | 0.092 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.132568e-01 | 0.090 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.166761e-01 | 0.088 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.173188e-01 | 0.088 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.173188e-01 | 0.088 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.173188e-01 | 0.088 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.173188e-01 | 0.088 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.173188e-01 | 0.088 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.173188e-01 | 0.088 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.173188e-01 | 0.088 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.173188e-01 | 0.088 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 8.173188e-01 | 0.088 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.173188e-01 | 0.088 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.173188e-01 | 0.088 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.176750e-01 | 0.087 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.176750e-01 | 0.087 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.176750e-01 | 0.087 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.176750e-01 | 0.087 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.195602e-01 | 0.086 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.195602e-01 | 0.086 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.200438e-01 | 0.086 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.263788e-01 | 0.083 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.263788e-01 | 0.083 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.278889e-01 | 0.082 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.294579e-01 | 0.081 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.302778e-01 | 0.081 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.302778e-01 | 0.081 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.303156e-01 | 0.081 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.303156e-01 | 0.081 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.303156e-01 | 0.081 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.303156e-01 | 0.081 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.303156e-01 | 0.081 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.303156e-01 | 0.081 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.311913e-01 | 0.080 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.337917e-01 | 0.079 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.337917e-01 | 0.079 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.337917e-01 | 0.079 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.337917e-01 | 0.079 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.337917e-01 | 0.079 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 8.337917e-01 | 0.079 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.337917e-01 | 0.079 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.337917e-01 | 0.079 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.337917e-01 | 0.079 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.337917e-01 | 0.079 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.337917e-01 | 0.079 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.337917e-01 | 0.079 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.337917e-01 | 0.079 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.337917e-01 | 0.079 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.356517e-01 | 0.078 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.404440e-01 | 0.075 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.404440e-01 | 0.075 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.404440e-01 | 0.075 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.404440e-01 | 0.075 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.421602e-01 | 0.075 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.421602e-01 | 0.075 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.429173e-01 | 0.074 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.435329e-01 | 0.074 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 8.445066e-01 | 0.073 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.484211e-01 | 0.071 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.487801e-01 | 0.071 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.487801e-01 | 0.071 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.487801e-01 | 0.071 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.487801e-01 | 0.071 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.487801e-01 | 0.071 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.487801e-01 | 0.071 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.487801e-01 | 0.071 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.487801e-01 | 0.071 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.487801e-01 | 0.071 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.487801e-01 | 0.071 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.487801e-01 | 0.071 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.487801e-01 | 0.071 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.500790e-01 | 0.071 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.500790e-01 | 0.071 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.507354e-01 | 0.070 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.529560e-01 | 0.069 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.529560e-01 | 0.069 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.530301e-01 | 0.069 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.532494e-01 | 0.069 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.532494e-01 | 0.069 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.532494e-01 | 0.069 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.532494e-01 | 0.069 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.582275e-01 | 0.066 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.582275e-01 | 0.066 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.592030e-01 | 0.066 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.592030e-01 | 0.066 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.624177e-01 | 0.064 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.624177e-01 | 0.064 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.624177e-01 | 0.064 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.624177e-01 | 0.064 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.636232e-01 | 0.064 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.636232e-01 | 0.064 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.636232e-01 | 0.064 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.678362e-01 | 0.062 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.678362e-01 | 0.062 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.733203e-01 | 0.059 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.733203e-01 | 0.059 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.748261e-01 | 0.058 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.748261e-01 | 0.058 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.748261e-01 | 0.058 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.748261e-01 | 0.058 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.748261e-01 | 0.058 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.759990e-01 | 0.057 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.759990e-01 | 0.057 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.759990e-01 | 0.057 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.766128e-01 | 0.057 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.776266e-01 | 0.057 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.788368e-01 | 0.056 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.817213e-01 | 0.055 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.823785e-01 | 0.054 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.823785e-01 | 0.054 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.829499e-01 | 0.054 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 8.837112e-01 | 0.054 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.837112e-01 | 0.054 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.851143e-01 | 0.053 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.851143e-01 | 0.053 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.851143e-01 | 0.053 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.861161e-01 | 0.053 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.861161e-01 | 0.053 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.861161e-01 | 0.053 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.861161e-01 | 0.053 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.861161e-01 | 0.053 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 8.874706e-01 | 0.052 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.878557e-01 | 0.052 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.908339e-01 | 0.050 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.963884e-01 | 0.048 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.963884e-01 | 0.048 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.963884e-01 | 0.048 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.963884e-01 | 0.048 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.963884e-01 | 0.048 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.963884e-01 | 0.048 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.963884e-01 | 0.048 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.963884e-01 | 0.048 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.968358e-01 | 0.047 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.980111e-01 | 0.047 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.983910e-01 | 0.047 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.987217e-01 | 0.046 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.987217e-01 | 0.046 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.987217e-01 | 0.046 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.987217e-01 | 0.046 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.987217e-01 | 0.046 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.043401e-01 | 0.044 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.043966e-01 | 0.044 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.043966e-01 | 0.044 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.057347e-01 | 0.043 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.057347e-01 | 0.043 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.057347e-01 | 0.043 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.057347e-01 | 0.043 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.060754e-01 | 0.043 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.060754e-01 | 0.043 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.060754e-01 | 0.043 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.074719e-01 | 0.042 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.104438e-01 | 0.041 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.104438e-01 | 0.041 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.129272e-01 | 0.040 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.129272e-01 | 0.040 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.142384e-01 | 0.039 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.142384e-01 | 0.039 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.142384e-01 | 0.039 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.142384e-01 | 0.039 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.142384e-01 | 0.039 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.142384e-01 | 0.039 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.142384e-01 | 0.039 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.142384e-01 | 0.039 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.143483e-01 | 0.039 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.161918e-01 | 0.038 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.172000e-01 | 0.038 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.216015e-01 | 0.035 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.219755e-01 | 0.035 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.219755e-01 | 0.035 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.219755e-01 | 0.035 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.219755e-01 | 0.035 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.219755e-01 | 0.035 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.219755e-01 | 0.035 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.219755e-01 | 0.035 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.219755e-01 | 0.035 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.219755e-01 | 0.035 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.252462e-01 | 0.034 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.266899e-01 | 0.033 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.282848e-01 | 0.032 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.290150e-01 | 0.032 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.290150e-01 | 0.032 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.290150e-01 | 0.032 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.290150e-01 | 0.032 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.307704e-01 | 0.031 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.307704e-01 | 0.031 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.307704e-01 | 0.031 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.328524e-01 | 0.030 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.342002e-01 | 0.030 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.354197e-01 | 0.029 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.354197e-01 | 0.029 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.354197e-01 | 0.029 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.354197e-01 | 0.029 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.354197e-01 | 0.029 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.354197e-01 | 0.029 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.354197e-01 | 0.029 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.354197e-01 | 0.029 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.357320e-01 | 0.029 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.359068e-01 | 0.029 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.359068e-01 | 0.029 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.359068e-01 | 0.029 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.359681e-01 | 0.029 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.395967e-01 | 0.027 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.395967e-01 | 0.027 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.396390e-01 | 0.027 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.401891e-01 | 0.027 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.406803e-01 | 0.027 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.406803e-01 | 0.027 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.412469e-01 | 0.026 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.412469e-01 | 0.026 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.412469e-01 | 0.026 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.412469e-01 | 0.026 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.412469e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.436652e-01 | 0.025 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.441510e-01 | 0.025 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.451147e-01 | 0.025 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.451147e-01 | 0.025 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.465486e-01 | 0.024 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.465486e-01 | 0.024 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.465486e-01 | 0.024 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.465486e-01 | 0.024 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.465486e-01 | 0.024 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.466980e-01 | 0.024 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.474210e-01 | 0.023 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.492321e-01 | 0.023 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.492321e-01 | 0.023 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.494260e-01 | 0.023 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.497987e-01 | 0.022 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.513536e-01 | 0.022 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.513722e-01 | 0.022 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.513722e-01 | 0.022 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.513722e-01 | 0.022 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.513722e-01 | 0.022 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.513722e-01 | 0.022 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 9.513722e-01 | 0.022 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.513722e-01 | 0.022 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.513722e-01 | 0.022 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.513722e-01 | 0.022 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.519507e-01 | 0.021 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.530537e-01 | 0.021 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.530537e-01 | 0.021 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.531628e-01 | 0.021 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.533886e-01 | 0.021 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.544717e-01 | 0.020 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 9.557608e-01 | 0.020 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 9.557608e-01 | 0.020 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.557608e-01 | 0.020 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.557608e-01 | 0.020 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.557608e-01 | 0.020 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.557608e-01 | 0.020 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.557608e-01 | 0.020 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.565994e-01 | 0.019 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.565994e-01 | 0.019 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.565994e-01 | 0.019 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.576815e-01 | 0.019 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.576815e-01 | 0.019 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.586573e-01 | 0.018 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 9.597535e-01 | 0.018 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 9.597535e-01 | 0.018 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.597535e-01 | 0.018 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.597535e-01 | 0.018 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.597535e-01 | 0.018 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.598877e-01 | 0.018 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.598877e-01 | 0.018 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.603759e-01 | 0.018 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.605480e-01 | 0.017 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.605480e-01 | 0.017 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.605480e-01 | 0.017 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.612321e-01 | 0.017 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.612321e-01 | 0.017 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.629363e-01 | 0.016 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.630996e-01 | 0.016 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.632914e-01 | 0.016 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.632914e-01 | 0.016 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.633861e-01 | 0.016 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.633861e-01 | 0.016 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.633861e-01 | 0.016 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.633861e-01 | 0.016 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.633861e-01 | 0.016 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.657420e-01 | 0.015 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.666910e-01 | 0.015 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.666910e-01 | 0.015 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.666910e-01 | 0.015 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.666910e-01 | 0.015 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.674810e-01 | 0.014 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.680904e-01 | 0.014 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.696978e-01 | 0.013 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.702861e-01 | 0.013 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.708031e-01 | 0.013 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.708031e-01 | 0.013 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.724333e-01 | 0.012 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.729433e-01 | 0.012 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.730474e-01 | 0.012 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.735223e-01 | 0.012 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.745967e-01 | 0.011 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.749221e-01 | 0.011 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.749221e-01 | 0.011 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.751247e-01 | 0.011 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.751248e-01 | 0.011 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.771862e-01 | 0.010 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.771862e-01 | 0.010 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.771862e-01 | 0.010 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.775428e-01 | 0.010 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.785467e-01 | 0.009 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.792461e-01 | 0.009 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.792461e-01 | 0.009 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.792461e-01 | 0.009 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.792461e-01 | 0.009 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.792461e-01 | 0.009 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.792461e-01 | 0.009 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.803998e-01 | 0.009 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.804680e-01 | 0.009 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.804680e-01 | 0.009 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.804680e-01 | 0.009 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.811201e-01 | 0.008 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.811201e-01 | 0.008 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.811201e-01 | 0.008 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.811201e-01 | 0.008 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.811201e-01 | 0.008 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.828250e-01 | 0.008 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.828250e-01 | 0.008 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.828250e-01 | 0.008 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.828250e-01 | 0.008 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.828250e-01 | 0.008 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.843760e-01 | 0.007 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.843760e-01 | 0.007 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.843760e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.843760e-01 | 0.007 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.843760e-01 | 0.007 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.846917e-01 | 0.007 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.850560e-01 | 0.007 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.857871e-01 | 0.006 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.857871e-01 | 0.006 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.857871e-01 | 0.006 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.858909e-01 | 0.006 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.869984e-01 | 0.006 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.869984e-01 | 0.006 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.870707e-01 | 0.006 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.870707e-01 | 0.006 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.870707e-01 | 0.006 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.870707e-01 | 0.006 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.880211e-01 | 0.005 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.880211e-01 | 0.005 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.881270e-01 | 0.005 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.882385e-01 | 0.005 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.882385e-01 | 0.005 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.882385e-01 | 0.005 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.882385e-01 | 0.005 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.883739e-01 | 0.005 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.883739e-01 | 0.005 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.889652e-01 | 0.005 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.893009e-01 | 0.005 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.893009e-01 | 0.005 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.895771e-01 | 0.005 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.900459e-01 | 0.004 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.902674e-01 | 0.004 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.902674e-01 | 0.004 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.902674e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.902674e-01 | 0.004 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.902674e-01 | 0.004 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.905536e-01 | 0.004 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.906405e-01 | 0.004 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.906405e-01 | 0.004 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.907249e-01 | 0.004 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.911467e-01 | 0.004 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.911467e-01 | 0.004 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.914813e-01 | 0.004 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.919465e-01 | 0.004 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.920665e-01 | 0.003 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.920904e-01 | 0.003 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.920904e-01 | 0.003 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.926741e-01 | 0.003 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.926741e-01 | 0.003 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.926741e-01 | 0.003 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.926741e-01 | 0.003 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.932103e-01 | 0.003 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.932792e-01 | 0.003 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.933235e-01 | 0.003 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.933361e-01 | 0.003 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.933361e-01 | 0.003 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.933361e-01 | 0.003 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.933361e-01 | 0.003 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.933361e-01 | 0.003 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.933361e-01 | 0.003 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.938155e-01 | 0.003 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.938575e-01 | 0.003 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.944860e-01 | 0.002 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.944860e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.945108e-01 | 0.002 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.949843e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.949843e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.951850e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.954376e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.955716e-01 | 0.002 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.958500e-01 | 0.002 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.962251e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.962251e-01 | 0.002 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.962251e-01 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.965575e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.965948e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.970914e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.973269e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.973269e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.978019e-01 | 0.001 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.978659e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.980574e-01 | 0.001 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.982312e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.983242e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.983912e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.983912e-01 | 0.001 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.983930e-01 | 0.001 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.984275e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.985367e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.991165e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.991716e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.991716e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.992465e-01 | 0.000 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.993173e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.993505e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.994331e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.994331e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.995658e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.995660e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.997075e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.997082e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.997331e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.997346e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.998365e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.998758e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998816e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998898e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999069e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999286e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999286e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999408e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999419e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999520e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999603e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999672e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999735e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999796e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999827e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999828e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999831e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999853e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999867e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999895e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999896e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999904e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999929e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999941e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999959e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999962e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999966e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999973e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999976e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999981e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999985e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999987e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999988e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999989e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999992e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999996e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999996e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999996e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999998e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |